The Cell

1. What Is a Cell?

A cell is the basic structural and functional unit of life. It is a bounded chemical system that maintains an internal environment, uses energy, responds to signals, regulates exchanges with its surroundings, and when its type and circumstances permit grows and reproduces. A human body is made of many specialized cell types working together rather than one uniform living material.

Cells are not tiny conscious decision-makers. Their activities emerge from chemical reactions, physical forces, genetic regulation, and interactions with other cells and the environment. Calling a cell a "factory" or "city" can help beginners visualize its organization, but these are analogies: cells do not have intentions, and biological processes are not literally industrial machines.

Most human cells contain a plasma membrane, cytoplasm, genetic material, and molecular machinery. Most have a nucleus and membrane-bound organelles. Mature human red blood cells are a major exception because they lose their nucleus and most organelles during development.

What does a cell need to stay alive?

Boundary and regulation: a membrane controls exchange and helps maintain internal conditions.
Information: DNA stores inherited instructions; RNA and proteins help use and regulate them.
Energy: cells transfer energy through molecules such as ATP (adenosine triphosphate).
Catalysis: enzymes accelerate chemical reactions.
Homeostasis: cells regulate variables such as ion concentrations, pH, volume, and nutrient availability.
Repair and turnover: cells replace damaged molecules and remove waste.
Communication: cells sense their surroundings and adjust their activity.

2. How the Human Body Is Organized

The body's organization can be described at several connected levels:

Molecules: water, ions, sugars, lipids, DNA, RNA, and proteins.
Cellular structures: membranes, ribosomes, mitochondria, and other compartments.
Cells: individual living units with specialized functions.
Tissues: groups of cells and their surrounding material working together.
Organs: structures containing multiple tissue types, such as the heart or liver.
Organ systems: coordinated organs, such as the circulatory or nervous system.
Organism: the integrated human body.

Three useful terms describe the material around cells:

Extracellular matrix (ECM): a network of proteins, carbohydrates, and other molecules outside cells. It provides mechanical support, helps organize tissues, and carries signals.
Extracellular fluid (ECF): fluid outside cells, including interstitial fluid between cells and blood plasma within blood vessels.
Interstitial fluid: the extracellular fluid bathing most tissue cells.

Important Point: the human body is not simply cells plus ECM plus fluid. It also contains blood, mineralized bone, stored substances, and other extracellular materials. The ECM is not all created by one cell type, and it is not present in the same amount everywhere. Some tissues have abundant matrix; others have cells packed closely together.

3. Cell Size, Shape, and Diversity

Cells vary in size and shape according to their functions. Measurements often use the micrometre (µm), equal to one-millionth of a metre, and the nanometre (nm), equal to one-billionth of a metre.

Example	Approximate scale	Why it matters
Many bacteria	Roughly 0.5–5 µm, though there are exceptions	Small size supports rapid exchange relative to volume.
Human red blood cell	About 7–8 µm across	Its flexible, biconcave shape supports gas exchange through narrow capillaries.
Many human cells	Often around 10–30 µm, with wide variation	There is no single "typical" size for all cell types.
Human egg cell	About 100 µm in diameter	It is large enough to be visible to the naked eye under suitable conditions.
Neurons	Cell bodies vary; some axons extend over very long distances	Their long processes support communication across the nervous system.

The relationship between surface area and volume affects how quickly materials can cross a cell boundary. As a cell grows, its volume increases faster than its surface area if its shape remains similar. Cells therefore use various strategies—including shape changes, internal transport, membrane folding, and division—to meet their exchange requirements.

Examples of specialized human cells

Neurons transmit and process information.
Red blood cells transport oxygen using haemoglobin.
Muscle cells generate force.
Epithelial cells cover surfaces, line cavities, and form barriers.
Adipocytes store and release energy-rich lipids and also signal to other tissues.
White blood cells participate in immune defence.
Fibroblasts produce and remodel extracellular matrix in many connective tissues.

4. The Chemistry Cells Depend On

Cells are made from atoms and molecules. Their behaviour depends on chemical bonds, molecular shape, concentration, temperature, electrical charge, and the surrounding aqueous environment.

4.1 Water and ions

Water is the principal solvent in cells. Its polarity allows it to surround many charged and polar molecules. Dissolved substances include ions such as sodium, potassium, calcium, chloride, magnesium, and phosphate.

These ions are not distributed equally across the plasma membrane. Cells maintain different concentrations inside and outside, and this difference contributes to membrane voltage, nutrient transport, electrical signalling, and muscle contraction.

4.2 Carbohydrates

Carbohydrates include simple sugars and larger sugar chains. Glucose can be used to produce energy, while other carbohydrates help form structural materials and molecular recognition labels.

Glucose is an important metabolic fuel.
Glycogen is a storage form of glucose in humans and other animals.
Glycoproteins are proteins with attached carbohydrate groups.
Glycolipids are lipids with carbohydrate groups, often involved in membrane recognition and organization.

4.3 Lipids

Lipids are a diverse group of molecules that includes fats, phospholipids, cholesterol, and steroid-related molecules. Many lipids do not dissolve well in water. This property is essential for building membranes.

Phospholipids have a water-interacting head group and water-avoiding hydrocarbon tails. In water, many phospholipids spontaneously form bilayers, which are the basic structural foundation of cellular membranes.

4.4 Proteins

Proteins are chains of amino acids that fold into structures with particular properties. They act as enzymes, receptors, channels, transporters, structural elements, motors, antibodies, and regulators.

A protein's function depends not only on its amino-acid sequence but also on folding, chemical modifications, location, binding partners, and the conditions around it. A change in any of these can alter protein activity.

4.5 DNA and RNA

DNA stores hereditary information in a sequence of chemical units called nucleotides. RNA helps express and regulate that information. Not all DNA directly encodes proteins; many regions help regulate genes or produce functional RNA molecules.

4.6 Enzymes and reaction rates

Enzymes are biological catalysts. They speed up chemical reactions by lowering the activation energy needed for a reaction to proceed. Enzymes do not make an energetically unfavourable reaction favourable by themselves; cells often couple reactions so that the overall process can proceed.

4.7 pH and buffering

pH describes acidity in terms of hydrogen-ion activity. Cellular reactions often work best within a limited pH range. Buffer systems resist sudden changes, and different compartments can maintain different pH values. For example, the cytosol is generally near neutral, while lysosomes maintain a more acidic interior.

5. Prokaryotic and Eukaryotic Cells

Life includes two broad cellular organizational patterns: prokaryotic cells and eukaryotic cells. Bacteria and archaea are prokaryotes. Animals, plants, fungi, and many single-celled organisms are eukaryotes.

Feature	Prokaryotic cells	Eukaryotic cells
Nucleus	No membrane-bound nucleus; DNA is located in a nucleoid region.	Usually have a membrane-bound nucleus.
Membrane-bound organelles	Generally lack the internal membrane-bound organelles typical of eukaryotes.	Have compartments such as the ER, Golgi apparatus, and mitochondria in many cell types.
DNA organization	Often have a main circular chromosome, with variation and possible plasmids.	Nuclear chromosomes are linear; mitochondria also contain DNA.
Ribosomes	Generally 70S ribosomes.	Generally 80S ribosomes in the cytosol; mitochondria have distinct ribosomes.
Typical size	Often smaller, but size varies widely.	Often larger, but size varies widely.

These are broad patterns, not absolute rules for every organism. Both groups contain sophisticated molecular machinery, and prokaryotes are not simply "primitive" versions of eukaryotic cells.

6. The Cell Membrane and Transport

The cell membrane is a selectively permeable boundary. It separates the cell's internal environment from the outside while allowing controlled movement of water, ions, nutrients, waste, and signals.

6.1 The phospholipid bilayer

The membrane's main structural framework is a lipid bilayer. The hydrophilic heads face the watery environments on either side, while the hydrophobic tails face inward toward one another.

The membrane is not a rigid wall. Many of its lipids and proteins move within the plane of the membrane. The arrangement is often described using the fluid mosaic model, although real membranes contain specialized regions and constraints.

6.2 Membrane proteins

Channels: create selective pathways for particular ions or molecules.
Carriers: bind substances and change shape to move them across the membrane.
Pumps: use energy, often from ATP, to move substances against gradients.
Receptors: detect chemical or physical signals.
Adhesion proteins: help cells attach to one another or to the extracellular matrix.
Enzymes: catalyse reactions at the membrane surface.

6.3 Simple diffusion

Diffusion is the net movement of particles down a concentration gradient due to random molecular motion. Small nonpolar molecules, including oxygen and carbon dioxide, can cross the lipid bilayer relatively easily. Charged ions and many large polar molecules generally require proteins.

6.4 Facilitated diffusion

Facilitated diffusion moves substances down their electrochemical gradients through membrane proteins without directly using ATP to drive that movement. Glucose transporters and many ion channels are examples.

6.5 Osmosis

Osmosis is the net movement of water across a selectively permeable membrane in response to differences in water potential. In biological contexts, the effect of a solution on cell volume depends particularly on its effective, non-penetrating solutes.

Hypotonic environment: water tends to enter a cell, which may swell.
Hypertonic environment: water tends to leave a cell, which may shrink.
Isotonic environment: there is no sustained net water movement that changes cell volume under the stated conditions.

6.6 Active transport

Active transport moves substances against their electrochemical gradients by coupling the process to an energy source.

The sodium–potassium pump uses ATP to move sodium out of the cell and potassium into the cell. This helps maintain ion gradients, cell volume, and the electrical properties needed for many types of signalling.

6.7 Secondary active transport

In secondary active transport, a transporter uses the energy stored in an ion gradient that another process established. For example, sodium movement down its gradient can help drive glucose uptake in certain epithelial cells.

6.8 Endocytosis and exocytosis

Endocytosis brings material into cells using membrane-derived vesicles. Exocytosis releases material when intracellular vesicles fuse with the plasma membrane. These processes are important for secretion, membrane maintenance, nutrient uptake, and cell communication.

7. Cytoplasm, Cytosol, and Compartments

The cytoplasm is the material inside the plasma membrane but outside the nucleus. It includes the cytosol, organelles, cytoskeleton, and many molecular complexes and stored materials.

The cytosol is the aqueous portion of the cytoplasm in which many reactions occur. It is crowded with proteins, metabolites, ions, and other molecules. It is not simply dilute water: molecular crowding and local organization influence how cellular reactions proceed.

Membrane-bound compartments allow different reactions to take place under different conditions. For example, lysosomes maintain an acidic interior, while the cytosol is usually much closer to neutral pH. Compartments help organize chemistry, but they still exchange materials and signals with the rest of the cell.

8. Nucleus, DNA, Chromosomes, and Gene Expression

The nucleus stores most of a human cell's genetic material. Its double membrane, called the nuclear envelope, separates the nuclear contents from the cytosol. The envelope contains nuclear pores that regulate traffic between these compartments.

8.1 DNA and chromosomes

Chromosomes contain DNA packaged with proteins. In most nucleated human somatic cells, the nucleus contains 46 chromosomes arranged in 23 pairs. There are important exceptions, including cells with unusual chromosome numbers and mature red blood cells, which lack a nucleus.

DNA is packaged with proteins including histones to form chromatin. Packaging helps fit DNA into the nucleus and also contributes to regulating which regions can be used by the cell.

8.2 Genes and gene expression

A gene is a region of DNA that contributes to a functional product, such as a protein or functional RNA. Gene expression includes processes that use genetic information to produce RNA and, for protein-coding genes, often proteins.

The simplified pathway for many protein-coding genes is:

Transcription: information in DNA is copied into RNA.
RNA processing: in human cells, many messenger RNA molecules are capped, spliced, and given a poly-A tail.
Translation: ribosomes read messenger RNA to build a chain of amino acids.
Protein maturation: the chain folds and may be modified, transported, or assembled with other molecules.

This is often called the central dogma of molecular biology. It is a useful introductory model, but actual gene regulation includes many additional layers, and not all genes encode proteins.

8.3 Types of RNA

Messenger RNA (mRNA) carries information used in translation.
Transfer RNA (tRNA) helps deliver amino acids during translation.
Ribosomal RNA (rRNA) forms a major part of ribosomes.

8.4 The nucleolus

The nucleolus is a dense nuclear region where ribosomal RNA is produced and processed and ribosomal subunits begin assembly. These subunits are then exported through nuclear pores and complete their functional assembly in the cytoplasm.

8.5 A clinical link: lamin A and progeria

Variants in LMNA, which encodes lamin A and lamin C, can cause several disorders. One rare condition, Hutchinson–Gilford progeria syndrome, is commonly associated with a variant that produces an abnormal lamin A form called progerin. This affects nuclear architecture and multiple cellular processes; it is not simply "a weak nucleus" alone.

9. Ribosomes and Protein Synthesis

Ribosomes are molecular complexes made of ribosomal RNA (rRNA) and proteins. They translate messenger RNA (mRNA) into a chain of amino acids that folds and may be modified to become a functional protein.

In eukaryotic cells, free cytosolic ribosomes have 40S and 60S subunits, which together form an 80S ribosome. The “S” refers to the Svedberg sedimentation unit, so these numbers do not add arithmetically. Mitochondria have their own ribosomes, which differ from cytosolic ribosomes.

Free ribosomes: make many proteins that remain in the cytosol or are later imported into the nucleus, mitochondria, and some other destinations.
ER-bound ribosomes: make many proteins entering the secretory pathway, including proteins secreted outside the cell, membrane proteins, and many lysosomal proteins.
Polysomes: groups of ribosomes translating the same mRNA at the same time.

Ribosomes do not permanently belong to the rough ER. A ribosome can begin translating an mRNA in the cytosol; a signal sequence and targeting machinery can direct the ribosome–nascent-chain complex to the ER. The destination of the protein is determined by targeting signals and cellular machinery.

9.1 Protein Quality Control

New proteins must fold into appropriate shapes. Molecular chaperones help proteins fold and reduce inappropriate aggregation. Damaged or misfolded proteins can be refolded, sequestered, or broken down by systems such as the ubiquitin–proteasome pathway.

10. Endoplasmic Reticulum (ER)

The endoplasmic reticulum (ER) is a connected network of membranes that helps synthesize, process, and transport proteins and lipids. It is continuous with the outer nuclear membrane.

10.1 Rough Endoplasmic Reticulum

The rough ER looks rough in electron micrographs because ribosomes are attached to its cytosolic surface. It is especially developed in cells that produce large amounts of secreted or membrane proteins, such as antibody-secreting plasma cells and many glandular cells.

Protein entry and folding: many newly made proteins enter the ER lumen or become embedded in the ER membrane.
Protein folding and quality control: chaperones such as BiP and calnexin help proteins acquire appropriate structures.
N-linked glycosylation: a preassembled sugar chain is attached to the nitrogen of certain asparagine residues in many proteins. This supports folding, quality control, stability, and later sorting.
Unfolded protein response (UPR): a group of signalling pathways activated by ER stress. It can increase folding capacity, reduce some protein synthesis, and promote disposal of misfolded proteins. Severe or prolonged stress may contribute to cell death.
ER-associated degradation (ERAD): selected misfolded ER proteins are moved toward the cytosol, tagged, and degraded by the proteasome.
Vesicle export: many proteins and lipids leave the ER in transport carriers that commonly use COPII coat proteins.

Proteins in the ER lumen are separated from the cytosol by the ER membrane. This compartment helps the cell control folding chemistry and protein processing.

10.2 Smooth Endoplasmic Reticulum

The smooth ER has few or no attached ribosomes on the region being described. Its abundance and functions vary by cell type.

Lipid synthesis: contributes to the production of phospholipids and other membrane lipids.
Steroid synthesis: participates in steroid hormone production in cells of the adrenal cortex and gonads, alongside mitochondria and other enzymes.
Drug and chemical metabolism: enzymes including members of the cytochrome P450 family modify many drugs and other compounds, especially in liver cells. These reactions can make compounds easier to eliminate, but can also activate some compounds or produce reactive metabolites.
Calcium storage: ER membranes store and release calcium, an important signal in many cells.
Glucose release in the liver: glucose-6-phosphatase, located in the ER membrane system, helps liver cells release free glucose from glucose-6-phosphate. This is part of glucose homeostasis, but not a universal smooth-ER function in every cell.

The sarcoplasmic reticulum is a specialized form of ER in muscle cells. It stores calcium and releases it through channels including ryanodine receptors to help initiate muscle contraction. ATP-driven calcium pumps return calcium to storage so the muscle can relax.

11. Golgi Apparatus and Vesicle Traffic

The Golgi apparatus is a stack of flattened membrane compartments called cisternae. It modifies, sorts, and packages many proteins and lipids received from the ER.

Cis face: the receiving side, generally oriented toward the ER.
Medial Golgi: intermediate processing compartments.
Trans face and trans-Golgi network: sorting and dispatch areas for many cargoes.

Golgi cisternae undergo maturation and exchange material through vesicles and tubules. It is too simple to picture the Golgi as a static stack in which every cargo merely travels through fixed, identical compartments.

11.1 Modifying Molecular Cargo

N-linked glycan processing: sugar chains added in the ER are trimmed and modified.
O-linked glycosylation: sugars are attached to oxygen atoms of selected amino-acid side chains, often serine or threonine.
Mannose-6-phosphate (M6P) tagging: helps direct many soluble lysosomal enzymes toward lysosomes.

11.2 Vesicle Coats and Routing

COPII: commonly supports transport from ER toward Golgi.
COPI: supports important retrograde transport pathways, including retrieval toward the ER and traffic within the Golgi.
Clathrin: forms coats used in selected trafficking routes, including endocytosis and transport from the trans-Golgi network.

Vesicles must recognize the correct destination. SNARE proteins and other factors help vesicles dock and fuse with target membranes. Mistargeting can disrupt secretion, membrane composition, and lysosomal function.

12. Mitochondria and Cellular Energy

Mitochondria are membrane-bound organelles central to energy metabolism, but they also participate in calcium handling, biosynthesis, signalling, and cell-death regulation. Their number and shape vary widely by cell type and energy demand.

12.1 Structure

Outer membrane: contains proteins, including porins, that permit passage of many small molecules but not unrestricted passage of everything.
Intermembrane space: the compartment between outer and inner membranes.
Inner membrane: contains the respiratory-chain complexes and ATP synthase. It is highly selective and folded into cristae.
Matrix: contains enzymes, mitochondrial DNA, RNA, ribosomes, and other components.

12.2 How ATP Is Produced

Cells extract usable energy from nutrients through connected metabolic pathways. In many human cells, mitochondrial cellular respiration is a major source of adenosine triphosphate (ATP).

Glycolysis: occurs in the cytosol and converts glucose into pyruvate, producing a small amount of ATP and reduced electron carriers.
Pyruvate oxidation: in aerobic metabolism, pyruvate-derived carbon enters mitochondrial pathways and is converted to acetyl-CoA.
Citric acid cycle (Krebs cycle): in the mitochondrial matrix, acetyl-CoA is oxidized, producing carbon dioxide and electron carriers.
Electron transport chain: electrons pass through protein complexes in the inner mitochondrial membrane. The released energy pumps protons across the membrane.
Chemiosmosis and ATP synthase: protons flow down their electrochemical gradient through ATP synthase, supporting ATP production. This process is called oxidative phosphorylation.

Oxygen is the final electron acceptor in the standard mitochondrial respiratory chain. When oxygen supply is limited, cells can rely more on glycolysis and convert pyruvate to lactate to regenerate NAD⁺. Lactate production is not exclusive to oxygen deprivation; it also occurs in normally oxygenated tissues under many conditions.

12.3 Mitochondrial DNA and Inheritance

Mitochondria have their own mitochondrial DNA (mtDNA), reflecting their evolutionary history. Human mtDNA encodes 13 proteins used in oxidative phosphorylation, along with mitochondrial rRNAs and tRNAs. Most mitochondrial proteins are encoded by nuclear DNA and imported into mitochondria. Mitochondrial inheritance in humans is usually maternal, though biological systems should not be reduced to an absolute statement about every conceivable case.

12.4 Mitochondria Beyond ATP

Mitochondria contribute to the synthesis of heme and iron–sulfur clusters, parts of amino-acid and lipid metabolism, calcium regulation, and signalling. Some pathways traditionally associated with mitochondria occur across multiple cellular locations. For example, the urea cycle and gluconeogenesis involve both mitochondrial and cytosolic steps; they do not occur entirely inside mitochondria.

12.5 Reactive Oxygen Species and Cell Death

Reactive oxygen species (ROS) can damage molecules at high levels, but they also function as signals at controlled levels. Antioxidant systems help regulate them. During some forms of intrinsic apoptosis, mitochondrial outer-membrane permeabilization allows cytochrome c to enter the cytosol and help activate a caspase cascade. This is regulated and is not simply the mitochondrion “exploding.”

13. Lysosomes, Autophagy, and Recycling

Lysosomes are membrane-bound compartments containing enzymes that break down many biological molecules. Their interior is acidic—often around pH 4.5–5—because V-type proton pumps move hydrogen ions inward using energy.

Lysosomal enzymes include proteases for proteins, nucleases for nucleic acids, lipases for lipids, and glycosidases for carbohydrates. The products of digestion can often be transported back into the cytosol and reused.

13.1 Autophagy

Autophagy is a set of processes by which cells deliver selected or bulk cytoplasmic material to lysosomes for degradation and recycling. In macroautophagy, a membrane structure encloses material to form an autophagosome, which then fuses with lysosomal compartments.

Mitophagy is selective autophagic removal of mitochondria. It helps maintain mitochondrial quality, although its regulation differs among cell types and circumstances.

13.2 Lysosomal Damage and Cell Death

The cytosol's near-neutral pH can reduce the activity of many lysosomal enzymes that escape from a lysosome, but it does not instantly and universally deactivate them. Extensive lysosomal membrane damage can still harm a cell and can contribute to several cell-death pathways.

Autolysis means self-digestion by cellular enzymes and is not synonymous with programmed cell death. Apoptosis is a regulated cell-death process; necrosis describes cell death associated with loss of membrane integrity and tissue damage, although modern cell biology recognizes multiple regulated forms of necrotic death.

13.3 Lysosomal Storage Diseases

When a lysosomal enzyme or transport protein is defective, particular substances can accumulate. These lysosomal storage diseases include conditions such as Gaucher disease and Tay–Sachs disease. The symptoms depend on which material accumulates and which tissues are affected.

14. Peroxisomes

Peroxisomes are small, single-membrane organelles involved in oxidative reactions and lipid metabolism. They contain oxidases that can generate hydrogen peroxide (H₂O₂), as well as catalase, which helps break it down.

Very-long-chain fatty acids: peroxisomes shorten certain fatty acids through oxidation pathways. Further processing can occur in mitochondria.
Reactive molecule handling: catalase and other enzymes manage peroxide chemistry. H₂O₂ is a reactive molecule, but it can also participate in regulated signalling.
Plasmalogen synthesis: peroxisomes perform essential early steps in producing plasmalogens, membrane lipids abundant in nervous tissue and other tissues.
Bile-acid and lipid metabolism: peroxisomes contribute to selected steps in processing certain lipids and bile-acid intermediates.

Peroxisomes are not merely detoxification sacs. Their role is specialized and coordinated with other organelles. Disorders affecting peroxisome formation or function can cause severe neurological and metabolic disease, such as Zellweger spectrum disorder.

15. The Cytoskeleton: The Cell's Internal Framework

The cytoskeleton is a dynamic network of protein filaments distributed throughout the cytoplasm. It helps cells maintain their shape, organize internal components, transport materials, move, divide, and respond to mechanical forces.

Unlike a rigid skeleton made of bone, the cytoskeleton can rapidly assemble, disassemble, bend, and reorganize. Its three major filament systems are actin filaments, intermediate filaments, and microtubules.

15.1 Actin Filaments (Microfilaments)

Actin is a protein that assembles into thin filaments, typically around 7 nanometres in diameter. These filaments are especially abundant beneath the plasma membrane, where they contribute to the cell cortex and help control the cell's shape.

Individual actin subunits are called globular actin, or G-actin. They assemble into filamentous actin, or F-actin. Assembly and disassembly depend on nucleotide binding, associated proteins, and local cellular conditions.

Major functions of actin filaments:

Cell shape: the actin-rich cell cortex helps maintain and change the shape of the cell surface.
Cell movement: actin polymerization can push the membrane forward to form structures such as lamellipodia and filopodia.
Muscle contraction: actin interacts with myosin motor proteins. In muscle, organized actin and myosin filaments slide relative to each other to generate force.
Cytokinesis: an actin–myosin contractile ring helps pinch one dividing animal cell into two daughter cells.
Endocytosis: actin helps deform and reorganize the membrane during certain forms of material uptake.
Cell adhesion: actin connects with protein complexes that attach cells to other cells or to the extracellular matrix.

Actin polymerization is carefully regulated by proteins such as profilin, cofilin, and the Arp2/3 complex. These regulators influence where filaments grow, branch, or disassemble.

15.2 Intermediate Filaments

Intermediate filaments are approximately 10 nanometres in diameter and provide mechanical strength. Unlike actin filaments and microtubules, they are not built from one universal protein; their components vary between cell types.

Examples include:

Keratins: abundant in epithelial cells and important for the mechanical strength of skin, hair, and nails.
Vimentin: common in many cells of mesenchymal origin, including fibroblasts.
Desmin: helps organize the contractile apparatus in muscle cells.
Neurofilaments: help maintain the structure and diameter of neuronal axons.
Lamins: form a supporting network beneath the inner nuclear membrane.

Intermediate filaments are particularly useful for resisting stretching and mechanical stress. Their defects can cause tissue-specific disorders. For example, certain keratin mutations cause skin fragility, while some lamin mutations affect nuclear structure and can produce disorders such as Hutchinson–Gilford progeria syndrome.

15.3 Microtubules

Microtubules are hollow cylindrical structures, typically about 25 nanometres in outer diameter. They are built from pairs of alpha-tubulin and beta-tubulin proteins.

Microtubules have structural polarity: one end is called the plus end and the other the minus end. Many microtubules grow and shrink dynamically, a behaviour called dynamic instability. This allows the cell to rapidly reorganize its internal architecture.

Major functions of microtubules:

Organizing the positions of organelles and helping establish cell polarity.
Providing tracks for intracellular transport.
Forming the mitotic spindle that separates chromosomes during cell division.
Building the internal scaffolding of cilia and eukaryotic flagella.
Contributing to the structure of long neuronal axons.

Proteins such as kinesins and dyneins move cargo along microtubules. Many kinesins move toward plus ends, whereas many cytoplasmic dyneins move toward minus ends, although the precise direction depends on the motor and cellular context.

15.4 Motor Proteins

Motor proteins convert chemical energy, usually from ATP hydrolysis, into mechanical work. They transport cargo, generate force, and help move cellular structures.

Myosin: generally interacts with actin filaments. Different myosin families perform roles in muscle contraction, vesicle movement, membrane tension, and other processes.
Kinesin: a family of motors that commonly transports cargo along microtubules toward their plus ends.
Dynein: a motor family that includes cytoplasmic dynein, which transports cargo toward microtubule minus ends, and axonemal dynein, which powers ciliary and flagellar beating.

Cargo may include vesicles, protein complexes, organelles, and RNA-containing particles. Motor proteins often work with adaptor proteins that connect a motor to its particular cargo.

15.5 Comparing the Three Major Filament Systems

Feature	Actin filaments	Intermediate filaments	Microtubules
Approximate diameter	7 nm	10 nm	25 nm
Main building blocks	Actin	Different proteins, depending on cell type	Alpha- and beta-tubulin
Mechanical role	Cell shape, tension, movement	Resistance to mechanical stress	Internal organization and long-range transport
Common motors	Myosins	No general motor system that walks along them	Kinesins and dyneins
Important examples	Muscle contraction, cell crawling, cytokinesis	Keratin networks, nuclear lamina	Mitotic spindle, cilia, intracellular transport

The cytoskeleton is not three independent systems operating in isolation. Its filaments interact with each other, the plasma membrane, organelles, motor proteins, and extracellular structures to coordinate cell behaviour.

16. Centrosomes and Centrioles

The centrosome is a major microtubule-organizing centre in many animal cells. It helps organize the microtubule network and commonly forms the two poles of the mitotic spindle during cell division.

16.1 Structure of the Centrosome

A typical animal-cell centrosome contains a pair of centrioles surrounded by protein-rich material called the pericentriolar material.

Centrioles: cylindrical structures usually arranged approximately at right angles to one another in a mature centrosome.
Pericentriolar material (PCM): contains proteins that recruit and organize microtubules. One important component is gamma-tubulin, which helps nucleate microtubules.
Microtubule nucleation: the process of initiating a new microtubule rather than simply extending an existing one.

Centrioles are built from organized microtubule structures. A typical centriole has nine sets of microtubule triplets arranged in a cylinder. This differs from the common nine doublets surrounding the central pair found in many motile cilia and flagella.

16.2 Centrosome Duplication and Cell Division

Before a cell divides, its centrosome normally duplicates through a tightly regulated process. The resulting centrosomes help organize the two poles of the mitotic spindle. The spindle's microtubules attach to chromosomes through specialized structures called kinetochores.

Errors in centrosome number or spindle organization can contribute to chromosome-segregation errors and aneuploidy, a condition in which cells have abnormal numbers of individual chromosomes.

16.3 Are Centrosomes Present in Every Cell?

No. Centrosomes with centrioles are typical of many animal cells, but plants and many other eukaryotes organize microtubules without a conventional centrosome containing centrioles. Even among animals, some differentiated cells modify or lose centrioles. Therefore, the centrosome is an important organizing centre, not a universal organelle in all eukaryotic cells.

Centrioles also help form basal bodies, which organize the microtubules of many cilia and flagella.

17. Storage Structures and Cellular Inclusions

Cells do not use every molecule immediately after producing or absorbing it. They may store nutrients for later energy production, accumulate substances needed for specialized functions, or temporarily hold products before releasing them. Other materials appear as by-products of normal metabolism or as substances that cells cannot easily break down.

These materials are often called cellular inclusions. Unlike major membrane-bound organelles, many inclusions are not enclosed by a conventional lipid bilayer. However, the category is broad: some storage structures, especially lipid droplets and certain specialized granules, have their own distinctive boundaries and associated proteins.

17.1 Why cells store materials

Storage allows a cell to separate the time when a substance is available from the time when it is needed. Nutrients may arrive irregularly, energy demand may change rapidly, and some substances must be kept at concentrations that are safe for the cell.

Energy reserves: glycogen and stored lipids provide fuel when immediate nutrient availability is insufficient.
Raw materials: cells retain molecules that can later be used to build membranes, proteins, nucleic acids, and other cellular components.
Specialized products: some cells store hormones, digestive enzymes, neurotransmitter-related cargo, or other secretions until an appropriate signal triggers release.
Protective sequestration: storing or isolating certain substances can limit their unwanted interactions with other cellular components.
Waste and residual materials: some long-lived cells accumulate pigments or incompletely degraded material over time.

17.2 Glycogen granules: storing glucose

Glycogen is a highly branched polymer of glucose. Its branched structure allows enzymes to add or remove glucose units at many chain ends, making glycogen a rapidly accessible carbohydrate reserve.

Glycogen is stored mainly in the cytoplasm as granules associated with enzymes and regulatory proteins. Two particularly important storage sites in humans are the liver and skeletal muscle, although their roles are different.

Liver glycogen: helps maintain blood glucose between meals. When blood glucose falls, the liver can break down glycogen and release glucose into the circulation, principally through glucose-6-phosphatase activity.
Skeletal-muscle glycogen: supplies glucose-derived fuel for the muscle's own activity. Skeletal muscle generally lacks the glucose-6-phosphatase activity needed to release substantial free glucose directly into the blood from its glycogen stores.

After a carbohydrate-containing meal, hormonal and metabolic signals generally promote glycogen synthesis when conditions permit. During fasting or exercise, other signals promote glycogen breakdown. These processes are regulated rather than being simple, continuous filling and emptying of a container.

Glycogen is useful for relatively rapid access to carbohydrate fuel, but its storage capacity is limited compared with the body's capacity to store energy as fat. Glycogen also binds water, so changes in glycogen stores can influence body weight without representing equivalent changes in body fat.

17.3 Lipid droplets: storing fat inside cells

Lipid droplets are cellular structures that store neutral lipids, particularly triglycerides and cholesteryl esters. They occur in many cell types, including adipocytes, liver cells, muscle cells, and cells that synthesize or transport lipids.

A typical lipid droplet has a core of hydrophobic neutral lipids surrounded by a phospholipid monolayer rather than the conventional bilayer found in most cellular membranes. Associated proteins regulate lipid storage, access, synthesis, and breakdown.

How lipid droplets form

Lipids such as triglycerides are synthesized within the endoplasmic reticulum or delivered through cellular lipid-handling pathways.
Neutral lipids accumulate between the two leaflets of the endoplasmic reticulum membrane.
As the lipid-rich region grows, it can form a droplet that emerges toward the cytosol.
Proteins associated with the droplet help regulate its growth, stability, and interaction with other organelles.

Lipid droplets are not merely passive fat deposits. They are dynamic structures that interact with mitochondria, the endoplasmic reticulum, and other cellular systems.

How stored lipids are used

When energy demand increases, enzymes can release fatty acids from stored triglycerides through lipolysis. Fatty acids may then be transported to mitochondria for oxidation, depending on the cell type and metabolic conditions. They can also be used to synthesize membrane lipids and signalling molecules.

In adipose tissue, lipid storage helps buffer the body's energy supply over time. In other tissues, lipid droplets may protect against excessive exposure to free fatty acids or provide locally available fuel. However, excessive or poorly regulated lipid accumulation in certain non-adipose tissues can contribute to cellular dysfunction.

17.4 Secretory granules: storing products before release

Some cells produce substances that must be released at the correct time rather than immediately after synthesis. These substances may be concentrated in membrane-bound secretory vesicles or granules.

Examples include:

Pancreatic beta cells: store insulin in secretory granules and release it in response to glucose and other regulatory signals.
Endocrine cells: store certain hormones for regulated secretion into the extracellular fluid and, in many cases, the bloodstream.
Neurons: store many neurotransmitters in synaptic vesicles near release sites. Some neuropeptides are stored in larger dense-core vesicles.
Exocrine gland cells: store digestive enzymes and other secretions before releasing them into ducts or onto epithelial surfaces.
Immune cells: some cells store enzymes and other active substances in granules that can be released under particular conditions.

Regulated secretion commonly involves a rise in intracellular calcium or another signal that promotes vesicle fusion with the plasma membrane. The vesicle membrane joins the cell membrane, and its contents are released by exocytosis.

This differs from constitutive secretion, in which many proteins and lipids are delivered to the cell surface or outside the cell as part of routine cellular maintenance without waiting for a special release signal.

17.5 Pigments and other accumulated materials

Some cells contain pigments or other substances that affect their colour or reflect their history of metabolism.

Melanin: a pigment produced by melanocytes and transferred to other cells, including keratinocytes in the skin. It absorbs a range of ultraviolet radiation and contributes to pigmentation, although it does not eliminate UV-related damage.
Lipofuscin: a yellow-brown material containing oxidized and incompletely degraded cellular components. It can accumulate in some long-lived cells, including certain neurons and cardiac muscle cells.
Hemosiderin: an iron-containing storage material that may accumulate when iron handling or breakdown of blood cells produces excess iron-containing material.

The presence of a pigment or inclusion does not automatically indicate disease. Its meaning depends on its chemical identity, quantity, location, and the biological context in which it occurs.

17.6 Inclusions, organelles, and cytoplasmic structures are not interchangeable terms

Cell biology uses overlapping terminology, and not every cellular structure fits neatly into a single category. A membrane-bound organelle generally has a specialized compartment and molecular machinery. An inclusion often refers to stored or accumulated material, but the term does not imply that every inclusion is biologically inactive or completely unstructured.

For example, a glycogen granule is a carbohydrate reserve associated with enzymes, while a lipid droplet has a phospholipid monolayer and a regulated set of associated proteins. A secretory granule is a membrane-bound compartment that participates in regulated transport and release. Their functions and structures are therefore different, even though all may be visible as distinct cellular contents.

17.7 How storage structures cooperate with other organelles

Storage is connected to the wider metabolic network. Glycogen breakdown supplies glucose-derived molecules for energy production. Lipid droplets exchange lipids with pathways involving the endoplasmic reticulum and can supply fatty acids to mitochondria. Secretory granules depend on protein synthesis, processing, membrane trafficking, and regulated exocytosis.

Storage also requires regulation. A cell must balance incoming nutrients, energy expenditure, synthesis, breakdown, and export. If this balance is disrupted, the consequences depend on the substance and the cell type: abnormal glycogen accumulation, excess lipid deposition, defective secretion, or accumulation of undegraded material can each affect cellular function in different ways.

Key idea: Cellular storage is an active, regulated part of metabolism. Stored material is useful only when the cell can access, mobilize, or release it at the appropriate time.

18. Extracellular Matrix, Cell Junctions, and Tissue Structure

Cells in a multicellular organism rarely operate as isolated units. They attach to neighbouring cells, interact with material outside the cell membrane, and experience forces produced by movement, fluid flow, stretching, and compression. These relationships help determine how tissues maintain their shape and how cells behave within them.

The extracellular matrix (ECM) is a network of proteins, carbohydrates, and associated molecules located outside cells. It provides structural support, but it also influences cell survival, migration, differentiation, and signalling. Cells produce, organize, sense, and remodel much of this matrix.

18.1 What the extracellular matrix does

The ECM performs several related functions:

Mechanical support: helps tissues resist pulling, compression, stretching, and deformation.
Cell attachment: provides binding sites that allow cells to attach to their surroundings.
Organization: helps arrange cells into tissue layers and maintain boundaries between tissue compartments.
Hydration: some ECM molecules attract water, helping tissues resist compression and maintain an appropriate extracellular environment.
Signalling: matrix molecules and their mechanical properties influence intracellular pathways and gene expression.
Repair and remodelling: changes in ECM production and breakdown help tissues respond to injury and normal wear.

The ECM is not identical in every tissue. Bone requires a mineral-reinforced matrix, cartilage needs a hydrated structure that resists compression, and tendons require highly organized fibres capable of transferring force. The composition of the matrix reflects the demands placed on each tissue.

18.2 Collagen: resistance to pulling forces

Collagen is a large family of structural proteins. Many collagen molecules assemble into strong extracellular structures that resist tensile forces. Different collagen types have distinct distributions and roles.

In many collagen types, three protein chains form a characteristic triple-helical structure. Collagen molecules can assemble into larger fibrils and fibres, with additional molecular organization and cross-links contributing to mechanical strength.

Skin: collagen helps resist tearing and excessive stretching.
Tendons and ligaments: organized collagen fibres transmit force and stabilize joints.
Bone: collagen provides an organic framework that combines with mineral to create a material that is strong but not simply brittle.
Basement membranes: specialized collagen types contribute to a thin supporting network beneath many epithelial layers.

Collagen is not a single uniform substance. Its type, arrangement, cross-linking, and surrounding molecules influence the properties of the tissue in which it occurs.

18.3 Elastin: stretch and recoil

Elastin helps certain tissues deform and then return toward their original shape. It is particularly important in elastic arteries, lungs, and some regions of the skin.

In elastic arteries, the ability of the wall to expand and recoil helps accommodate pulsatile blood flow. In the lungs, elastic components contribute to the tendency of lung tissue to recoil after expansion. Elastin works alongside collagen and other matrix components rather than acting alone.

18.4 Proteoglycans and glycosaminoglycans: water, spacing, and compression

Proteoglycans consist of a core protein attached to one or more carbohydrate chains called glycosaminoglycans. Many glycosaminoglycans carry strong negative charges that attract counterions and promote water retention.

This hydration helps certain tissues resist compression and supports the movement of molecules through the extracellular environment.

Cartilage: proteoglycans, including aggrecan, help the tissue retain water and resist compressive loading.
Basement membranes and other matrices: particular proteoglycans contribute to organization, molecular interactions, and selective permeability.
Connective tissues: proteoglycans can influence the spacing and assembly of structural fibres.

Water retention is not simply a matter of making tissue soft. The combination of hydrated molecules, collagen, and other matrix components gives tissues their characteristic mechanical behaviour.

18.5 Fibronectin, laminin, and the attachment of cells to matrix

Fibronectin is an extracellular glycoprotein that can bind cells and other matrix components. It participates in cell attachment, migration, wound repair, and the organization of some matrix structures.

Laminins are major components of many basement membranes. They help organize the basement-membrane network and interact with cell-surface receptors.

These proteins do not merely glue cells in place. Their interactions with receptors can influence cell polarity, survival, movement, and differentiation. Cells can also change how they attach by altering receptor expression, receptor activation, and the matrix around them.

18.6 Basement membranes: specialized extracellular sheets

A basement membrane is a specialized layer of extracellular matrix beneath many epithelial tissues and around certain other cell types. It contains an organized network of molecules, including laminins, collagen IV, and associated proteins.

Basement membranes help separate tissue compartments, provide structural support, and influence cell behaviour. In the kidney, specialized basement-membrane structures form part of the filtration barrier. In epithelial tissues, the basement membrane supports the cell layer and helps maintain its organization.

A basement membrane is not the same as the plasma membrane. The plasma membrane encloses the cell; the basement membrane is outside the cell and forms part of the extracellular environment.

18.7 How cells sense and attach to the extracellular matrix

Integrins are transmembrane proteins that connect extracellular ligands to intracellular structures and signalling pathways. Many integrins bind ECM molecules outside the cell and associate with cytoskeletal and signalling proteins inside it.

Through these connections, cells can respond to both chemical information and physical forces. This process is often discussed under the term mechanotransduction.

For example, a cell may respond differently to a soft matrix than to a stiff one. The response depends on cell type, receptor activity, cytoskeletal organization, and many other factors. Mechanical signals can influence movement, gene expression, growth, and differentiation.

Cells also attach to the matrix through specialized structures such as focal adhesions and hemidesmosomes. These structures differ in their molecular composition and functions.

18.8 Cell junctions: connecting neighbouring cells

Cell junctions are specialized arrangements of proteins that connect cells to one another or attach cells to the extracellular matrix. Their roles include sealing spaces, transmitting force, coordinating activity, and maintaining tissue integrity.

Tight junctions

Tight junctions are especially important in epithelial and endothelial barriers. They restrict the movement of many substances through the spaces between adjacent cells, although the degree of sealing varies by tissue.

Tight junctions also help maintain cell polarity by limiting the mixing of certain membrane components between the apical and basolateral regions of epithelial cells.

Adherens junctions

Adherens junctions connect neighbouring cells through adhesion proteins linked to the actin cytoskeleton. They help tissues maintain cohesion and can transmit forces between cells.

These junctions are important during tissue development and shape changes, when groups of cells must reorganize in a coordinated way.

Desmosomes

Desmosomes provide strong cell-to-cell attachment by connecting adhesion proteins to intermediate filaments. They are particularly important in tissues that experience repeated mechanical stress, such as the epidermis and cardiac muscle.

Gap junctions

Gap junctions form channels between adjacent cells. These channels allow selected ions and small molecules to pass directly between the connected cytoplasms.

Gap junctions can help coordinate the electrical and chemical behaviour of neighbouring cells. They are important in tissues such as cardiac muscle, where intercellular communication contributes to coordinated activity. They do not permit unrestricted passage of all cellular contents.

Hemidesmosomes and focal adhesions

Hemidesmosomes attach certain epithelial cells to the basement membrane, linking extracellular matrix components to the cell's intermediate-filament system.

Focal adhesions are dynamic cell–matrix attachment structures often associated with integrins and the actin cytoskeleton. They can help cells grip a surface, generate traction during migration, and sense mechanical conditions.

Hemidesmosomes and focal adhesions are both involved in cell–matrix attachment, but they differ in their molecular organization, cytoskeletal connections, and typical roles.

18.9 Comparing major cell junctions

Structure	Main connection or role	Important feature
Tight junction	Seals or regulates the space between cells	Helps control paracellular movement and maintain epithelial polarity
Adherens junction	Connects neighbouring cells	Linked to actin and helps transmit mechanical force
Desmosome	Provides strong cell-to-cell adhesion	Linked to intermediate filaments
Gap junction	Allows selected small molecules and ions to pass between cells	Creates direct cytoplasmic communication
Hemidesmosome	Attaches a cell to the basement membrane	Connects extracellular attachment machinery to intermediate filaments
Focal adhesion	Attaches a cell to the ECM	Dynamic structure involved in traction, migration, and mechanosensing

18.10 How the ECM differs among tissues

Bone: collagen-rich matrix reinforced with mineral, mainly hydroxyapatite. The combination provides stiffness and strength while retaining some resistance to fracture.
Cartilage: a hydrated matrix rich in proteoglycans and collagen that helps resist compression and supports relatively smooth movement at joints.
Tendons: densely organized collagen fibres transmit force from muscle to bone.
Skin: collagen, elastin, and other matrix components contribute to strength, flexibility, and recoil.
Blood: blood cells are suspended in plasma rather than embedded in a conventional dense, solid-tissue ECM.
Basement-membrane-rich tissues: specialized matrix layers provide support and compartment boundaries beneath epithelial surfaces and around some other cells.

18.11 ECM remodelling, wound healing, and disease

The ECM is continuously modified. Cells synthesize matrix molecules, assemble them, attach to them, and remove or reorganize them. Enzymes such as matrix metalloproteinases can break down components of the matrix, allowing tissues to remodel their structure.

During wound healing, cells coordinate inflammation, cell migration, matrix deposition, and tissue repair. Fibroblasts can produce collagen and other matrix components, while other cells remove damaged material and help restore the tissue surface. The resulting matrix may differ from the original tissue, particularly when repair produces a scar.

ECM regulation also matters in disease. Excessive matrix deposition can contribute to fibrosis, while abnormal degradation or organization can weaken tissue structure. Changes in matrix stiffness and cell–matrix signalling may also influence tumour behaviour, although the effects depend on the cancer type and tissue environment.

Key idea: Tissue structure depends on both cells and their extracellular environment. Junctions connect cells to one another, the ECM supports and informs cells, and continuous remodelling helps tissues adapt, repair, and maintain function.

19. Cell Communication and Signalling

Cells must continuously respond to information from their surroundings and from other cells. They detect nutrients, hormones, growth factors, neurotransmitters, immune signals, mechanical forces, and changes in their internal environment. They then convert this information into responses such as altered enzyme activity, gene expression, movement, secretion, division, or cell death.

Cell signalling is the process through which a cell detects a signal and produces an appropriate response. It connects individual cellular activities to the coordinated functioning of tissues, organs, and entire organisms.

19.1 Why cells need signalling

A cell cannot respond appropriately to every possible environmental change in the same way. It needs mechanisms that allow it to detect relevant information and select a suitable response.

Homeostasis: signalling helps maintain variables such as blood glucose, ion concentrations, fluid balance, and blood pressure within workable ranges.
Growth and division: growth factors and other signals can encourage cells to grow or divide when appropriate.
Differentiation: signals help developing cells acquire specialized structures and functions.
Coordination: cells communicate to synchronize activities such as muscle contraction, digestion, and immune responses.
Defence: immune cells use signalling molecules to recruit other cells, activate antimicrobial mechanisms, and regulate inflammation.
Survival and death: cells integrate survival signals, stress signals, and internal damage signals when determining whether to continue functioning or activate a death pathway.

Signalling does not mean that a cell consciously interprets information. The response emerges from molecular interactions, biochemical reactions, electrical changes, and gene-regulatory mechanisms.

19.2 The basic stages of cell signalling

Although signalling pathways vary considerably, many can be described using three broad stages: reception, transduction, and response.

Reception: a receptor detects a signal or a change in the cellular environment.
Signal transduction: the receptor activates or modifies intracellular molecules, passing the information through a series of biochemical events.
Cellular response: the cell changes its activity, for example by opening an ion channel, modifying an enzyme, releasing a substance, or altering gene expression.

The pathway may also include termination or adaptation mechanisms. Without these, a signal could remain active for too long or prevent the cell from responding appropriately to new information.

One signal may activate several downstream pathways, and several different signals may converge on the same cellular process. Consequently, the response depends not only on the signal itself but also on the receptors, signalling proteins, cellular state, and other signals present at the time.

19.3 Major types of cell communication

Endocrine signalling

Endocrine signalling involves hormones released into the circulation to influence target cells, often at a distance from the cells that produced them.

For example, pancreatic beta cells release insulin in response to appropriate metabolic signals. Insulin reaches target tissues through the blood and activates insulin receptors. Its effects differ among tissues: it promotes glucose uptake in skeletal muscle and adipose tissue, influences liver metabolism, and regulates the storage and use of nutrients.

Endocrine signalling can be relatively slow compared with some electrical or synaptic events, but its duration varies considerably. Hormones differ in their transport, clearance, receptor mechanisms, and effects.

Paracrine signalling

Paracrine signalling occurs when a cell releases a signalling molecule that acts on nearby cells. The signal often spreads through the local extracellular environment and is limited by diffusion, uptake, or degradation.

Examples include growth factors acting on neighbouring cells, local inflammatory mediators, and signalling molecules involved in tissue repair. Paracrine signalling allows a group of nearby cells to coordinate activity without requiring every message to travel through the bloodstream.

Autocrine signalling

In autocrine signalling, a cell releases a signal that acts on receptors on the same cell or on cells of the same type nearby.

Autocrine signalling can help regulate immune activation, growth, and cell-state transitions. It can also contribute to pathological signalling when a cell develops mechanisms that sustain its own growth or survival.

Synaptic signalling

Neurons commonly communicate at specialized junctions called synapses. An electrical signal reaching the presynaptic terminal can trigger the release of neurotransmitters, which cross a narrow gap and bind receptors on the target cell.

Chemical synapses can produce excitatory, inhibitory, or modulatory effects depending on the neurotransmitter, receptor, and target cell. Not every neurotransmitter has the same effect in every context.

At a neuromuscular junction, for example, motor neurons release acetylcholine, which activates receptors on skeletal muscle fibres and initiates a sequence leading to contraction.

Contact-dependent signalling

Some signalling requires direct contact between cells. A signalling molecule attached to one cell's surface binds a receptor on an adjacent cell. This is important in immune recognition, tissue development, and the regulation of cell fate.

Contact-dependent signalling differs from the release of a freely diffusible signal because physical proximity and cell-surface interactions are essential to the process.

Mechanical signalling

Cells also respond to physical forces such as stretching, compression, fluid shear, and changes in the stiffness of their surroundings. These inputs can alter ion-channel activity, cytoskeletal tension, adhesion complexes, and intracellular signalling pathways.

This process is called mechanotransduction. It is important in tissues such as bone, blood vessels, muscle, and the developing embryo.

19.4 Receptors: how cells detect signals

A receptor is a molecule that recognizes a signal and initiates or modifies a response. Many receptors are proteins, although signalling systems can also involve other molecular sensors.

Receptors differ in location, structure, binding properties, and mechanism of action. The chemical properties of a signal help determine which receptors it can reach and activate.

Cell-surface receptors

Many signalling molecules, including peptide hormones and many growth factors, are water-soluble and cannot readily cross the hydrophobic interior of the plasma membrane. Their receptors are therefore located at the cell surface.

When a ligand binds, the receptor may change shape, assemble with other proteins, activate an enzyme, open an ion channel, or initiate an intracellular signalling cascade.

Intracellular receptors

Some signals can cross cellular membranes and bind receptors inside the cell. Steroid hormones are an important example. Many steroid receptors regulate gene expression by interacting with DNA-associated regulatory machinery after activation.

Other intracellular receptors detect signals in the cytoplasm or nucleus. The exact response depends on the receptor and the signal involved.

19.5 G protein-coupled receptors

G protein-coupled receptors (GPCRs) form a large family of cell-surface receptors. They respond to many types of signals, including hormones, neurotransmitters, and sensory stimuli.

When a ligand activates a GPCR, the receptor promotes a change in a coupled heterotrimeric G protein. The G protein's alpha subunit exchanges GDP for GTP, and the activated components can regulate downstream targets.

Depending on the pathway, these targets may include adenylyl cyclase, phospholipase C, or ion channels.

Example: the cAMP pathway

A signalling molecule binds a GPCR.
The activated receptor regulates a G protein.
The G protein influences adenylyl cyclase activity.
Adenylyl cyclase converts ATP into cyclic AMP, commonly called cAMP.
cAMP activates or regulates proteins such as protein kinase A.
Downstream proteins are modified, changing cellular activity.

cAMP acts as a second messenger. Its effects depend on which proteins are present and where the signalling components are organized inside the cell.

The pathway is not always activated in the same direction. Different GPCRs couple to different G proteins and can activate or inhibit particular downstream processes.

19.6 Receptor tyrosine kinases

Receptor tyrosine kinases (RTKs) are cell-surface receptors that phosphorylate tyrosine residues on proteins. Many respond to growth factors and regulate growth, survival, metabolism, migration, and differentiation.

In a typical RTK pathway, ligand binding promotes receptor activation, often through receptor pairing or rearrangement. The activated receptors phosphorylate tyrosine residues on themselves or associated proteins, creating sites where additional signalling proteins can bind.

One major downstream route is the Ras–Raf–MEK–ERK pathway, commonly grouped under the mitogen-activated protein kinase (MAPK) signalling network.

A growth factor binds its receptor.
The receptor becomes activated and phosphorylates relevant tyrosine residues.
Adaptor proteins help activate Ras, a small GTP-binding protein.
Ras activates Raf, which activates MEK.
MEK activates ERK.
ERK modifies proteins in the cytoplasm and nucleus, influencing cellular behaviour and gene expression.

This pathway is important in normal growth and development. Abnormal activation of components such as Ras or B-Raf can also contribute to cancer, illustrating how the same signalling machinery can support normal physiology or disease depending on how it is regulated.

19.7 Second messengers

Second messengers are small intracellular molecules or ions that relay and amplify signals after a receptor is activated. The extracellular signalling molecule is often called the first messenger.

Important examples include:

cAMP: regulates proteins such as protein kinase A and influences processes including metabolism and gene expression.
Calcium ions (Ca²⁺): participate in muscle contraction, secretion, enzyme regulation, and many other responses.
Inositol trisphosphate (IP₃): can stimulate the release of calcium from intracellular stores, particularly the endoplasmic reticulum.
Diacylglycerol (DAG): remains associated with membranes and helps activate certain protein kinase C pathways.
Cyclic GMP (cGMP): participates in pathways including nitric-oxide signalling and phototransduction in the retina.

These messengers do not all perform the same role. Their concentrations, locations, timing, and target proteins determine their effects.

19.8 Calcium signalling

Calcium ions are especially versatile signalling molecules. Cells keep free calcium concentration in the cytosol tightly regulated because prolonged or excessive elevation can disrupt cellular function.

Calcium signals can arise from calcium entering through the plasma membrane or being released from intracellular stores. The endoplasmic reticulum is a major calcium store in many cell types.

Calcium can bind proteins such as calmodulin, which then regulates target enzymes and other proteins. In muscle cells, specialized calcium-handling machinery links electrical excitation to contraction. In secretory cells, calcium can help trigger vesicle fusion and release.

Calcium signalling is often temporary. Pumps, exchangers, and uptake mechanisms remove calcium from the cytosol or return it to storage compartments, allowing the cell to restore its resting state and respond to subsequent signals.

19.9 Signal amplification, specificity, and integration

Signalling pathways often amplify information. One activated receptor may influence several intracellular molecules, each of which can influence multiple downstream targets. This makes it possible for a relatively small extracellular signal to produce a substantial response.

However, amplification does not mean that every signal produces the same result. Specificity depends on several factors:

Receptor distribution: only cells with the relevant functional receptor can respond directly through that receptor.
Receptor abundance: the number of receptors can affect sensitivity and the magnitude of the response.
Intracellular machinery: different cells may express different downstream proteins.
Signal duration: a brief signal can produce a different response from a prolonged signal.
Signal location: where a messenger or active protein is produced can influence which targets it reaches.
Cross-talk: one pathway can modify another, allowing the cell to integrate several inputs.

For example, the same hormone may produce different effects in the liver, skeletal muscle, and adipose tissue because those tissues have different metabolic roles and different combinations of enzymes and regulatory proteins.

19.10 Feedback and signal termination

Signalling pathways must be regulated so that the response matches the conditions that produced it. Two broad forms of feedback are commonly discussed.

Negative feedback: a response reduces the activity of the process that initiated it or limits further signalling. This often stabilizes a biological system.
Positive feedback: a response reinforces the initiating process. This can create rapid transitions or sustain a response until a stopping mechanism intervenes.

Negative feedback is common in homeostatic regulation. Positive feedback can be useful in processes such as blood clotting and certain stages of cellular activation, where a strong coordinated response is required.

Cells terminate or reduce signalling through mechanisms such as ligand removal, receptor internalization, GTP hydrolysis by G proteins, degradation of second messengers, dephosphorylation of proteins, and inhibition of downstream components.

Cells can also become less responsive to persistent stimulation. This is often called desensitization. It prevents continuous exposure to a signal from necessarily producing a continuously increasing response.

19.11 When signalling goes wrong

Abnormal signalling can arise from mutations, altered receptor abundance, defective regulatory proteins, inappropriate ligand production, or environmental conditions that disrupt normal control.

Diabetes: impaired insulin production, insulin action, or both can disrupt glucose regulation.
Cancer: changes in growth-promoting and growth-inhibiting pathways can contribute to uncontrolled proliferation or survival.
Inflammatory disease: excessive, prolonged, or misdirected inflammatory signalling can damage tissues.
Neurological disorders: changes in neurotransmitter production, receptor function, ion channels, or signalling pathways can affect nervous-system function.
Developmental disorders: disrupted signalling gradients or pathway activity can alter the formation and organization of tissues.

These conditions are biologically diverse. A disease should not be reduced to a single signalling molecule without considering the wider cellular and physiological context.

Key idea: Cell signalling converts information into action. Receptors detect signals, intracellular pathways transmit and integrate them, and feedback mechanisms help control the strength, duration, and termination of the response.

20. Cellular Metabolism and ATP

Cells constantly transform matter and energy. They synthesize proteins, membranes, nucleic acids, and other molecules; transport substances across membranes; move; divide; maintain ion gradients; and repair damage. These activities require energy and a continuous supply of usable chemical building blocks.

Metabolism is the complete network of chemical reactions occurring in an organism or cell. It includes reactions that break down molecules, reactions that synthesize new molecules, and pathways that transfer energy between different chemical forms.

20.1 Catabolism and anabolism

Metabolism is often divided into two broad categories: catabolism and anabolism. These terms describe general functions rather than two completely separate systems.

Catabolism

Catabolism includes pathways that break down molecules into smaller products. Many catabolic reactions release usable energy or transfer electrons to carrier molecules.

Examples include:

Breaking down glucose through glycolysis and subsequent pathways.
Oxidizing fatty acids to produce acetyl-CoA and reduced electron carriers.
Breaking down some amino acids and processing their carbon skeletons.

Anabolism

Anabolism includes pathways that build larger or more complex molecules from smaller precursors. These reactions often require energy and reducing power.

Examples include:

Protein synthesis from amino acids.
DNA and RNA synthesis from nucleotide precursors.
Fatty-acid and membrane-lipid synthesis.
Glycogen synthesis from glucose-derived molecules.

Catabolism and anabolism are connected. Catabolic pathways provide energy, precursors, and reducing equivalents that anabolic pathways can use. Cells regulate these processes to avoid wasteful cycles and to match production with demand.

20.2 What ATP is and why cells need it

Adenosine triphosphate (ATP) is a nucleotide that plays a central role in cellular energy transfer. It consists of adenine, ribose, and three phosphate groups.

ATP hydrolysis can be coupled to cellular processes that require a favourable change in free energy. In a common reaction, ATP is hydrolysed to ADP and inorganic phosphate:

ATP + H₂O → ADP + P_i

The reaction's usable free-energy change depends on the concentrations of ATP, ADP, phosphate, and other relevant conditions. ATP is not simply a container of energy that releases a fixed amount whenever a phosphate bond is broken. Its usefulness arises from the thermodynamics of the overall reaction and the way cells couple it to other processes.

ATP supports many types of work:

Chemical work: drives or supports biosynthetic reactions.
Transport work: powers pumps that move substances against electrochemical gradients.
Mechanical work: supports molecular motors involved in muscle contraction, intracellular transport, and other movements.
Regulatory functions: phosphate transfer from ATP can alter the activity of proteins and enzymes.

ATP is continually regenerated and consumed. Cells generally maintain a relatively small immediately available ATP pool and turn it over rapidly rather than relying on a large stockpile of ATP for long-term energy storage.

20.3 ATP is not the only important energy carrier

ATP is central, but metabolism relies on several other molecules to transfer electrons, chemical groups, and energy.

NADH: carries high-energy electrons from many metabolic reactions. Its electrons can help drive ATP production through the respiratory chain.
NADPH: supplies reducing power for many biosynthetic reactions and antioxidant defence systems.
FADH₂: is a reduced electron carrier used in pathways including the citric acid cycle.
Acetyl-CoA: carries an acetyl group and connects carbohydrate, lipid, and some amino-acid metabolism to the citric acid cycle and biosynthetic pathways.
Coenzyme A: participates in the transfer of acyl groups in many metabolic reactions.

NADH and NADPH are both electron carriers, but they have different typical roles. NADH is closely associated with energy metabolism, while NADPH is especially important for reductive biosynthesis and protection against oxidative stress. This division is useful but not absolute in every organism or cellular context.

20.4 Enzymes: controlling the speed of metabolism

Enzymes are biological catalysts that accelerate chemical reactions by lowering the activation energy required for the reaction to proceed. Most enzymes are proteins, although some RNA molecules also have catalytic activity.

An enzyme binds one or more substrates and facilitates their conversion into products. The enzyme is not normally consumed by the reaction, although it can be damaged, degraded, or chemically modified over time.

Enzymes are selective, but selectivity varies. An enzyme may act on one substrate or on a family of related molecules. Its activity can depend on temperature, pH, substrate availability, cofactors, inhibitors, and regulatory signals.

How cells regulate enzymes

Substrate availability: a reaction may slow when its required substrate becomes scarce.
Allosteric regulation: a molecule binds at a regulatory site and changes enzyme activity.
Covalent modification: phosphorylation or another chemical modification can change an enzyme's activity or interactions.
Feedback inhibition: a product or downstream metabolite inhibits an earlier step in a pathway.
Gene expression: cells can increase or decrease the amount of enzyme they produce.
Compartmentalization: separating reactions into different cellular locations helps control which enzymes and substrates can interact.

Metabolic regulation is therefore more complex than simply turning an enzyme on or off. Cells often regulate entire pathways through multiple interacting mechanisms.

20.5 Glucose metabolism: an overview

Glucose metabolism provides a useful example of how cellular pathways connect. Depending on the cell type and conditions, glucose can be oxidized to produce energy, stored as glycogen, or used as a precursor for biosynthesis.

When glucose is broken down for energy under aerobic conditions, its carbon atoms can ultimately be oxidized to carbon dioxide, while oxygen serves as the final electron acceptor in mitochondrial oxidative phosphorylation.

The main stages of glucose oxidation in many human cells are:

Glycolysis: glucose is converted into pyruvate in the cytosol.
Pyruvate oxidation: pyruvate is converted into acetyl-CoA, mainly in the mitochondrial matrix in cells with functional mitochondria.
Citric acid cycle: acetyl-CoA-derived carbon is oxidized, producing reduced electron carriers.
Oxidative phosphorylation: electron transport and the proton gradient drive ATP synthesis across the inner mitochondrial membrane.

These stages are connected but distinct. Glycolysis can occur without oxygen being directly consumed by the pathway. The later stages of complete glucose oxidation in mitochondria depend on conditions that allow electron transport and the regeneration of electron carriers.

20.6 Glycolysis: breaking glucose into pyruvate

Glycolysis is a sequence of enzyme-catalysed reactions that converts one six-carbon glucose molecule into two three-carbon pyruvate molecules.

Glycolysis occurs in the cytosol and does not directly require oxygen. It is therefore available to many different cell types, including cells that lack mitochondria.

The pathway has two broad phases:

Energy-investment phase: ATP is consumed to phosphorylate and prepare glucose-derived intermediates for breakdown.
Energy-payoff phase: later reactions generate ATP and NADH as the intermediates are converted into pyruvate.

For each glucose molecule processed through the conventional pathway, the net direct yield is two ATP and two NADH, along with two pyruvate molecules.

The net reaction can be summarized as:

Glucose + 2 NAD⁺ + 2 ADP + 2 P_i → 2 pyruvate + 2 NADH + 2 ATP + 2 H⁺ + 2 H₂O

This is a simplified overall representation; exact chemical accounting depends on how the reaction is written and on cellular ionisation conditions.

What happens to pyruvate?

Pyruvate is an important metabolic branch point. Its fate depends on the cell, oxygen availability, mitochondrial function, and metabolic demand.

Oxidative metabolism: in cells with functional mitochondria and suitable conditions, pyruvate can be converted into acetyl-CoA and oxidized through the citric acid cycle.
Lactate formation: lactate dehydrogenase can convert pyruvate into lactate while regenerating NAD⁺, allowing glycolysis to continue.
Other pathways: pyruvate can contribute to pathways such as gluconeogenesis or amino-acid metabolism, depending on the cell and physiological state.

Lactate production does not occur only when oxygen is completely absent. Many cells produce lactate even when oxygen is available, especially when glycolytic flux is high or when the balance between pyruvate production and mitochondrial oxidation favours lactate formation.

20.7 Lactate and anaerobic energy production

Lactate is produced when lactate dehydrogenase transfers electrons from NADH to pyruvate, forming lactate and regenerating NAD⁺.

This regeneration is important because glycolysis requires NAD⁺ for one of its oxidation steps. If NAD⁺ becomes insufficient, glycolysis cannot continue at its normal rate.

When lactate is formed from glucose-derived pyruvate, glycolysis still provides a net yield of two ATP per glucose. Lactate formation itself does not produce an additional ATP in this conversion.

Lactate is not simply a waste product. It can be transported between tissues and used as a metabolic fuel or converted back into pyruvate. The liver can use lactate-derived carbon for glucose production under appropriate conditions.

Red blood cells rely on glycolysis for ATP because mature human red blood cells lack mitochondria. Other tissues can use both glycolysis and mitochondrial metabolism, with the relative contribution depending on the situation.

20.8 Pyruvate oxidation and acetyl-CoA formation

In cells with functioning mitochondria, pyruvate can enter the mitochondrial matrix and be converted into acetyl-CoA by the pyruvate dehydrogenase complex.

This reaction links glycolysis to the citric acid cycle. For each pyruvate molecule converted, carbon dioxide is released and NADH is produced.

The reaction is often summarized as:

Pyruvate + CoA + NAD⁺ → acetyl-CoA + CO₂ + NADH

The pyruvate dehydrogenase complex is regulated according to cellular conditions. Its activity is influenced by mechanisms including phosphorylation, the availability of substrates and cofactors, and signals reflecting the cell's energy state.

Acetyl-CoA is not used only for energy production. It also participates in fatty-acid synthesis and other biosynthetic processes. Its destination depends on the metabolic state of the cell and on the compartment in which it is produced.

20.9 The citric acid cycle

The citric acid cycle, also called the Krebs cycle or tricarboxylic acid cycle, is a series of reactions that oxidizes acetyl-CoA-derived carbon and produces reduced electron carriers.

In human cells, most reactions of the cycle occur in the mitochondrial matrix, although succinate dehydrogenase is embedded in the inner mitochondrial membrane and also functions as Complex II of the electron transport chain.

The cycle begins when acetyl-CoA contributes a two-carbon acetyl group to oxaloacetate, forming citrate. Through a series of reactions, the carbon atoms are processed, electron carriers are reduced, and oxaloacetate is regenerated.

For each acetyl-CoA oxidized through one turn of the cycle, the conventional net yield is:

Three NADH molecules.
One FADH₂ equivalent.
One GTP or ATP, depending on the cellular enzyme system.
Two carbon dioxide molecules.

The cycle is not simply a one-way fuel-burning pathway. Its intermediates are also used to make amino acids, heme, and other cellular materials. When intermediates are withdrawn for biosynthesis, replenishing reactions help maintain the cycle's operation.

For this reason, the citric acid cycle is described as amphibolic: it participates in both catabolic and anabolic metabolism.

20.10 The electron transport chain

The electron transport chain in mitochondria consists of protein complexes and mobile electron carriers in the inner mitochondrial membrane. Electrons from NADH and other sources pass through the chain in a series of redox reactions.

In the main pathway, electrons from NADH enter through Complex I. Electrons from succinate-derived FADH₂ enter through Complex II. Both routes can pass electrons to ubiquinone, then to Complex III, cytochrome c, and Complex IV.

At Complex IV, electrons are transferred to oxygen, which combines with protons to form water. Oxygen is therefore the final electron acceptor in mitochondrial oxidative phosphorylation under aerobic conditions.

Complexes I, III, and IV use energy from electron transfer to pump protons from the mitochondrial matrix into the intermembrane space. Complex II does not pump protons.

This creates an electrochemical gradient across the inner mitochondrial membrane. The gradient stores potential energy that can be used to synthesize ATP.

20.11 Oxidative phosphorylation and ATP synthase

Oxidative phosphorylation couples electron transport to ATP synthesis. It is a major source of ATP in many aerobic human cells.

As protons accumulate on the intermembrane-space side of the inner mitochondrial membrane, they tend to flow back toward the matrix. The inner membrane is normally relatively impermeable to protons, so much of this return occurs through specific proteins, including ATP synthase.

ATP synthase uses the proton-motive force to drive the formation of ATP from ADP and inorganic phosphate. Its molecular components undergo conformational and rotational changes that couple proton movement to ATP synthesis.

This process illustrates an important principle: energy from chemical reactions can be converted into an electrochemical gradient and then used to drive another chemical reaction.

The coupling is not perfectly efficient in every circumstance. Protons can return across the membrane through routes that do not produce ATP, and cells can regulate mitochondrial coupling according to physiological needs.

20.12 How much ATP is produced from one glucose molecule?

The total ATP yield from glucose oxidation is not a universal fixed number. It depends on the cell, the transport of cytosolic reducing equivalents into mitochondria, the efficiency of oxidative phosphorylation, and other physiological conditions.

For many human cells, a commonly used approximate estimate is about 30–32 ATP per glucose molecule during complete aerobic oxidation. This is an estimate rather than an exact yield guaranteed in every cell.

Stage	Main location	Important products per glucose
Glycolysis	Cytosol	2 net ATP, 2 NADH, 2 pyruvate
Pyruvate oxidation	Mitochondrial matrix in typical human cells	2 NADH, 2 acetyl-CoA, 2 CO₂
Citric acid cycle	Mainly mitochondrial matrix	6 NADH, 2 FADH₂, 2 GTP or ATP, 4 CO₂
Oxidative phosphorylation	Inner mitochondrial membrane	Most ATP generated during complete aerobic glucose oxidation

The table summarizes the conventional pathway. It should not be interpreted as meaning that all cells generate the same ATP yield from glucose under all conditions.

20.13 Why mitochondria do not make all cellular ATP

Mitochondria are major ATP-producing organelles in many cells, but ATP can be produced elsewhere.

Glycolysis produces ATP in the cytosol through substrate-level phosphorylation. The citric acid cycle also includes a substrate-level phosphorylation step that produces GTP or ATP. In addition, certain specialized tissues and cellular conditions rely heavily on glycolysis.

Mature human red blood cells lack mitochondria and depend on glycolysis for their ATP supply. Some cells and tissues can increase glycolytic ATP production during high demand or when oxygen delivery is limited.

ATP production and consumption are also spatially organized. Some ATP-consuming processes are supplied by nearby enzymes or local metabolic pathways, while other ATP and energy carriers are transported between cellular compartments.

20.14 Fatty-acid oxidation and energy storage

Fatty acids are an important fuel, especially during fasting, prolonged exercise, and other conditions in which the body mobilizes stored fat.

In a common mitochondrial pathway, fatty acids are first activated to fatty acyl-CoA. Many long-chain fatty acids then use the carnitine shuttle to reach the mitochondrial matrix. There, beta-oxidation breaks the fatty-acid chain into acetyl-CoA units while producing NADH and FADH₂.

Acetyl-CoA can enter the citric acid cycle when the necessary metabolic conditions are present. The reduced electron carriers can supply electrons to the respiratory chain and support ATP production.

Fatty-acid oxidation yields substantial energy because fatty acids are highly reduced molecules. However, the rate and extent of oxidation depend on substrate delivery, cellular regulation, oxygen availability for sustained oxidative metabolism, and the cell's capacity to process the resulting products.

Fatty acids are not only fuels. They are also components of membranes and precursors for certain signalling molecules. Cells must therefore balance their use for energy with their roles in structure and regulation.

20.15 Protein and amino-acid metabolism

Proteins are essential cellular components, but amino acids can also contribute to energy metabolism. When amino acids are used as fuel or metabolic precursors, their nitrogen-containing groups must be handled appropriately.

Depending on the amino acid, its carbon skeleton can enter metabolism at different points, including as pyruvate, acetyl-CoA, or intermediates of the citric acid cycle.

The removal or transfer of amino groups involves reactions such as transamination and deamination. In humans, nitrogen disposal is closely connected to the urea cycle in the liver.

Amino-acid metabolism must be coordinated with protein synthesis, tissue maintenance, and the availability of other fuels. Protein is not simply an interchangeable substitute for carbohydrate or fat, because proteins also perform essential structural, catalytic, transport, and regulatory functions.

20.16 Metabolism in the fed and fasting states

Metabolism changes according to nutrient availability and physiological demand. Hormones such as insulin and glucagon help coordinate these changes, particularly in the liver, muscle, and adipose tissue.

After a meal

When nutrients are absorbed and insulin rises in response to the metabolic state, the body generally increases nutrient uptake and storage processes where appropriate. Glycogen synthesis, lipid synthesis, and protein synthesis may increase depending on tissue and conditions.

During fasting

As the time since the last meal increases, the body relies more heavily on stored fuels. The liver initially uses glycogen breakdown to help maintain blood glucose and also increases gluconeogenesis as needed. Adipose tissue can release fatty acids through lipolysis, supplying fuel to many tissues.

During prolonged fasting, the liver can produce ketone bodies from fatty-acid-derived acetyl-CoA. Some tissues can use ketone bodies as fuel, and the brain increases its use of ketones during prolonged starvation, reducing but not eliminating its glucose requirement.

These are broad patterns, not rigid switches. Several pathways operate simultaneously, and their relative contributions change over time.

20.17 Glycolysis versus oxidative phosphorylation

Feature	Glycolysis	Oxidative phosphorylation
Primary location	Cytosol	Inner mitochondrial membrane in typical human cells
Direct oxygen requirement	Does not directly consume oxygen	Normally depends on oxygen as the final electron acceptor in the respiratory chain
ATP generation	Substrate-level phosphorylation	ATP synthase uses the proton-motive force
Relative ATP yield	Low direct yield per glucose	Produces most ATP during complete aerobic glucose oxidation in many cells
Availability	Can operate in cells without mitochondria	Requires functional oxidative-phosphorylation machinery

These pathways are complementary rather than mutually exclusive. Many cells use glycolysis and oxidative phosphorylation together, and their relative activity changes with energy demand and metabolic conditions.

20.18 Reactive oxygen species and antioxidant defence

Cellular metabolism can generate reactive oxygen species (ROS), chemically reactive molecules that include superoxide and hydrogen peroxide. Mitochondrial electron transport is one source, but enzymes and other cellular reactions also produce ROS.

ROS are not exclusively harmful. At controlled levels, certain reactive molecules participate in signalling. At excessive levels or in the wrong cellular location, they can damage DNA, proteins, lipids, and other components.

Cells use antioxidant systems to control reactive species. These include enzymes such as superoxide dismutases, catalase, and glutathione peroxidases, along with non-enzymatic molecules and repair systems.

The biological outcome depends on the balance between reactive-species production, antioxidant capacity, damage repair, and the role of ROS in signalling. It is therefore inaccurate to treat every ROS molecule as a toxin or every antioxidant reaction as automatically beneficial.

20.19 Energy metabolism and ion gradients

Cells use energy not only to build molecules but also to maintain differences in ion concentration across membranes. These differences are called electrochemical gradients.

For example, the sodium–potassium pump uses ATP to transport sodium ions out of the cell and potassium ions into it. This contributes to ion gradients that are essential for electrical signalling, cell-volume regulation, and secondary active transport.

Other transport proteins use existing gradients to move substances that cannot cross membranes freely. In this way, energy used to establish a gradient can indirectly support many additional cellular processes.

In mitochondria, the proton gradient across the inner membrane supports ATP synthesis. In many cells, gradients across the plasma membrane also help drive nutrient uptake and the movement of ions.

20.20 Metabolic flexibility and cellular stress

Cells can adjust their use of fuels in response to changing conditions. This ability is often called metabolic flexibility, although its meaning varies by context.

For example, muscle cells may alter the relative use of carbohydrates and fatty acids depending on exercise intensity and duration. Liver cells change their metabolic activity according to feeding and fasting. Immune cells can alter their metabolic pathways as they activate, proliferate, or carry out specialized functions.

When energy supply fails to meet demand, cells may reduce energy-consuming processes, mobilize stored resources, alter gene expression, or activate stress-response pathways. Severe or prolonged metabolic failure can disrupt ion gradients, damage cellular components, and threaten cell survival.

Metabolic dysfunction may contribute to disease, but it rarely has a single universal cause. The relevant pathways and consequences depend on the tissue, the underlying disorder, and the duration and severity of the disturbance.

Key idea: Metabolism connects the flow of matter with the flow of energy. ATP provides a common means of coupling energy-releasing reactions to cellular work, while enzymes, electron carriers, membranes, and regulatory pathways coordinate the process.

21. Cell Cycle, Mitosis, and Meiosis

Cells must reproduce to support growth, replace damaged or old cells, and enable organisms to reproduce. Before a cell divides, it must coordinate growth, DNA replication, chromosome organization, and the distribution of genetic material. These events form part of the cell cycle.

Cell division is not simply the splitting of a cell into two. A successful division requires the genome to be copied accurately, chromosomes to be distributed correctly, and cellular components to be allocated to the resulting daughter cells. Errors can produce cells with abnormal chromosome numbers, damaged DNA, or impaired function.

21.1 The main stages of the cell cycle

In many eukaryotic cells, the cell cycle is divided into interphase and the M phase. Interphase includes G1, S, and G2. The M phase includes nuclear division and usually cytokinesis, which divides the cytoplasm.

G1 phase: the cell grows, carries out normal functions, produces proteins and other components, and assesses whether conditions support another round of division.
S phase: the cell replicates its nuclear DNA so that each chromosome will have two sister chromatids.
G2 phase: the cell continues growing and prepares for division. It also checks aspects of DNA replication and cellular readiness.
M phase: the duplicated chromosomes are separated during mitosis, followed by or coordinated with division of the cytoplasm.

Some cells leave the active cycle and enter a non-dividing state commonly called G0. This state can be temporary or long-lasting, depending on the cell type and circumstances. Many differentiated cells perform specialized functions without frequently dividing, while other cells can re-enter the cycle in response to appropriate signals.

Not every cell follows an identical schedule. Cell-cycle duration varies greatly by cell type, developmental stage, environmental conditions, and physiological demand.

21.2 G1 phase: growth and preparation

During G1, the cell increases or maintains its cellular machinery and evaluates whether it should proceed toward DNA replication. It may synthesize RNA, proteins, membrane components, and other molecules required for later stages.

Progression through G1 is influenced by nutrients, growth factors, energy availability, cell size, DNA integrity, and signals from neighbouring cells. These inputs help determine whether further division is appropriate.

Cells do not divide merely because they have grown large enough. They integrate multiple signals, and different cell types have different requirements for entering the cycle.

21.3 S phase: copying the genome

During DNA replication, each chromosome's DNA is copied. The process is semiconservative: each newly produced DNA double helix contains one original strand and one newly synthesized strand.

Replication begins at multiple origins across the eukaryotic genome. Enzymes separate the DNA strands, synthesize complementary strands, and join DNA fragments where necessary. DNA polymerases add nucleotides in a defined direction, while other proteins help unwind DNA, stabilize single strands, remove primers, and seal gaps.

Because DNA polymerases cannot begin a new strand entirely on their own, replication requires primers. The leading strand is synthesized relatively continuously, whereas the lagging strand is synthesized in shorter segments called Okazaki fragments that are subsequently processed and joined.

DNA replication is highly accurate but not perfect. Polymerase proofreading, mismatch repair, and other repair mechanisms reduce the number of errors that persist in the genome.

Chromosomes and sister chromatids

Before replication, a replicated-chromosome diagram is often represented as a single chromosome consisting of one chromatid. After DNA replication, that chromosome consists of two sister chromatids associated with one another, particularly around the centromeric region.

The chromosome count does not simply double when DNA is replicated. In a typical human diploid somatic cell, the cell has 46 chromosomes before replication and still has 46 chromosomes after S phase, but each chromosome now contains two sister chromatids. The amount of nuclear DNA has approximately doubled.

After sister chromatids separate during mitosis, each chromatid is considered an individual chromosome. Each daughter nucleus normally receives one copy of every chromosome.

21.4 G2 phase: checking readiness for division

G2 provides time for continued growth, preparation of division machinery, and assessment of DNA replication. Cells can delay progression when replication is incomplete or DNA damage is detected.

DNA-damage responses activate signalling pathways that can pause the cycle, promote repair, or, when damage cannot be managed appropriately, contribute to long-term arrest or cell death.

These control mechanisms are important because dividing with an incompletely replicated or severely damaged genome can produce mutations, chromosome abnormalities, or daughter cells that cannot function normally.

21.5 Cell-cycle checkpoints

Cell-cycle checkpoints are regulatory systems that help prevent cells from progressing through critical stages when important requirements have not been met.

G1/S control: evaluates conditions such as growth signals, nutrients, cell state, and DNA damage before the cell commits to DNA replication.
Intra-S-phase control: helps coordinate DNA replication with the response to replication stress or DNA damage.
G2/M control: helps prevent entry into mitosis when DNA replication is incomplete or important DNA damage remains unresolved.
Spindle assembly checkpoint: delays chromosome separation until chromosomes have achieved appropriate attachment to the spindle apparatus.

Checkpoints do not guarantee that every DNA error will be corrected or that every abnormal cell will be eliminated. They are regulatory systems that reduce risks, and their effectiveness depends on the integrity of the proteins and pathways involved.

21.6 Cyclins and cyclin-dependent kinases

Cell-cycle progression is controlled partly by cyclin-dependent kinases (CDKs). These enzymes phosphorylate target proteins and help coordinate transitions between cell-cycle stages.

CDK activity is regulated by proteins called cyclins, whose levels rise and fall during the cycle. Different cyclin–CDK complexes participate in different transitions, although their precise roles vary across organisms and cell types.

Additional controls include inhibitory proteins, activating or inhibitory phosphorylation, protein degradation, and signals from DNA-damage responses. The combined system helps ensure that major events occur in the correct order.

For example, the degradation of particular cyclins is important for exiting mitosis. This illustrates why cell-cycle regulation depends not only on making proteins but also on removing them at the appropriate time.

21.7 Mitosis: dividing the nucleus

Mitosis is the process by which a eukaryotic cell separates duplicated chromosomes into two daughter nuclei. It supports growth, tissue maintenance, and many forms of asexual reproduction.

Mitosis is commonly described using prophase, prometaphase, metaphase, anaphase, and telophase. These names describe a continuous process rather than completely isolated events.

Prophase

Chromosomes become more condensed and easier to distinguish microscopically. The mitotic spindle begins to form from microtubules and associated proteins. In animal cells, centrosomes generally move toward opposite sides of the cell as the spindle develops.

Chromosome condensation helps organize long DNA molecules for reliable movement. It does not mean that the DNA has been newly copied during prophase; replication occurred earlier during S phase.

Prometaphase

In the conventional description of open mitosis in many animal cells, the nuclear envelope breaks down during prometaphase. Spindle microtubules can then access the chromosomes and interact with protein structures called kinetochores, assembled at centromeric regions.

Microtubules attach to kinetochores, and chromosomes undergo movements as attachments are established and corrected. Proper attachment is important because each sister chromatid must eventually be connected to the appropriate spindle pole.

Not all eukaryotes undergo the same form of nuclear-envelope breakdown. Some organisms carry out closed or partially closed mitosis.

Metaphase

Chromosomes become positioned near the cell's equatorial plane, commonly called the metaphase plate. Sister kinetochores are generally attached to microtubules originating from opposite spindle poles.

The spindle assembly checkpoint monitors aspects of chromosome attachment and delays anaphase when required. Correct alignment and attachment reduce the chance that daughter cells will receive incorrect chromosome numbers.

Anaphase

When the cell is ready to proceed, sister-chromatid cohesion is released through regulated mechanisms. Sister chromatids separate and move toward opposite spindle poles.

Chromosome movement involves microtubule dynamics and associated motor proteins. At the same time, spindle poles may move apart, depending on the organism and cell type.

This is a critical stage because chromosome-segregation errors can produce aneuploid daughter cells, meaning cells with abnormal numbers of individual chromosomes.

Telophase

Chromosomes arrive near the opposite poles and begin to decondense. In many forms of open mitosis, nuclear envelopes re-form around the chromosome sets, restoring two nuclei.

The cell then completes or continues cytokinesis, depending on the timing and coordination of nuclear and cytoplasmic division.

21.8 The mitotic spindle and chromosome movement

The mitotic spindle is a dynamic structure built largely from microtubules and associated proteins. It organizes and separates chromosomes during mitosis.

Microtubules are polymers made from tubulin proteins. They can grow and shrink, allowing the spindle to explore space, establish attachments, and change its geometry.

Kinetochores connect chromosomes to spindle microtubules. Cohesin complexes help hold sister chromatids together before separation, while regulated removal or cleavage of cohesin allows anaphase to proceed.

The spindle must coordinate attachment, tension, chromosome alignment, and separation. Errors can cause chromosome loss, chromosome gain, or structural damage, which is why spindle regulation is a major component of faithful cell division.

21.9 Cytokinesis: dividing the cytoplasm

Cytokinesis divides the cytoplasm to produce separate daughter cells. Its mechanism differs between many animal and plant cells.

Animal cells

In many animal cells, an actin–myosin contractile ring forms beneath the plasma membrane. Contraction of this ring creates a cleavage furrow that progressively constricts the cell until the daughter cells separate.

Final separation requires coordinated remodelling of membranes and cytoskeletal structures. Cytokinesis is therefore more than simply pinching the cell in half.

Plant cells

Plant cells have a rigid cell wall that prevents cytokinesis by the same type of furrow used by many animal cells. Instead, membrane-bound vesicles gather at the centre of the dividing cell and fuse to form a cell plate.

The cell plate expands outward and develops into the new separating structure between daughter cells, eventually contributing to the new cell wall and associated membranes.

21.10 What mitosis produces

In a typical mitotic division, a diploid parent cell produces two daughter cells that usually retain the same chromosome number as the parent. If the parent is a human diploid somatic cell and chromosome segregation occurs correctly, each daughter nucleus normally receives 46 chromosomes.

However, the phrase “genetically identical daughter cells” is an approximation. Mutations, DNA damage, chromosome-segregation errors, and differences in cellular contents can create variation between daughter cells. Gene expression and cell behaviour can also differ even when their DNA sequences are very similar.

Mitosis is essential for replacing cells in tissues such as the intestinal epithelium and skin. It also supports wound repair and early development. Mature cell populations differ considerably in their ability to divide, and some specialized cells rarely or never undergo ordinary mitosis.

21.11 Meiosis: producing haploid cells

Meiosis is a specialized form of cell division associated with sexual reproduction. It reduces the chromosome complement from diploid to haploid and contributes to genetic variation.

In humans, meiosis occurs in the germline during the formation of sperm and eggs. The details of gamete formation differ between males and females, including the timing of meiotic stages and the distribution of cytoplasm.

Meiosis includes one round of DNA replication followed by two divisions:

Meiosis I: homologous chromosomes separate, reducing the chromosome complement.
Meiosis II: sister chromatids separate in a process with important similarities to mitosis.

Because DNA is replicated before meiosis I but not again between meiosis I and meiosis II, the two divisions produce cells with a reduced chromosome complement.

21.12 Homologous chromosomes and sister chromatids

Humans normally have 23 pairs of homologous chromosomes in diploid somatic cells. One chromosome of each pair was inherited from the biological mother and the other from the biological father.

Homologous chromosomes carry the same general sets of genes at corresponding locations, but they may contain different versions of those genes, called alleles. Homologous chromosomes are not normally identical copies of one another.

Sister chromatids, in contrast, are produced by replication of one chromosome. They are usually very similar in DNA sequence, although replication errors and DNA damage can create differences.

This distinction is central to meiosis: homologous chromosomes pair and separate during meiosis I, while sister chromatids separate during meiosis II.

21.13 Prophase I and crossing over

Prophase I of meiosis includes events that are not part of ordinary mitotic prophase. Homologous chromosomes pair through a process called synapsis, and DNA exchange can occur between non-sister chromatids.

Crossing over involves the exchange of DNA segments between homologous chromosomes. The resulting recombinant chromosomes contain combinations of genetic variants that differ from those on the original chromosome copies.

Crossing over contributes to genetic diversity and helps establish physical connections between homologous chromosomes that support their correct segregation during meiosis I.

The number and locations of crossovers are regulated. Not every region of every chromosome pair experiences a crossover, and abnormal recombination can contribute to reproductive problems or chromosome-segregation errors.

21.14 Meiosis I: separating homologous chromosomes

During metaphase I, homologous chromosome pairs align at the cell's equatorial region. Their orientation is not fixed in advance in a way that forces every maternal chromosome to travel with every other maternal chromosome.

At anaphase I, homologous chromosomes separate toward opposite poles. Sister chromatids remain associated with each other at this stage, although the mechanisms regulating cohesion differ between chromosome regions.

This division reduces the chromosome complement. A human cell entering meiosis I has 46 replicated chromosomes. After meiosis I, each resulting cell normally contains 23 chromosomes, each still consisting of two sister chromatids.

21.15 Meiosis II: separating sister chromatids

Meiosis II resembles mitosis in the way sister chromatids are separated, but it begins with haploid cells containing replicated chromosomes rather than with a typical diploid cell following S phase.

During meiosis II, chromosomes align, sister-chromatid cohesion is released through regulated mechanisms, and the chromatids move to opposite poles. The resulting cells contain haploid chromosome sets.

In the simplified human example, each final haploid nucleus contains 23 chromosomes. The chromosomes may carry recombinant DNA combinations produced during meiosis I.

21.16 Why meiosis creates genetic variation

Meiosis creates genetic variation through multiple mechanisms:

Crossing over: exchanges DNA between homologous chromosomes, producing recombinant chromosomes.
Independent assortment: homologous chromosome pairs orient and separate in different combinations during meiosis I.
Fertilization: in sexual reproduction, the combination of genetic material from two gametes creates additional variation among offspring.

Mutation also contributes to genetic variation, but it is not the same process as crossing over or independent assortment. Mutation changes DNA sequence, while recombination rearranges existing sequence variants into new combinations.

Genetic variation is important for populations and evolution, but not every variation is beneficial. Variants may be neutral, harmful, or advantageous depending on the environment and genetic background.

21.17 Mitosis and meiosis compared

Feature	Mitosis	Meiosis
Main role	Growth, repair, replacement, and some forms of asexual reproduction	Production of haploid reproductive cells or their precursors in sexual life cycles
DNA replication	Once before the division	Once before meiosis I, with no new replication before meiosis II
Number of nuclear divisions	One	Two
First major separation	Sister chromatids separate	Homologous chromosomes separate in meiosis I
Homologous pairing and crossing over	Not a standard feature of ordinary mitosis	Important features of prophase I
Typical result	Two daughter cells	Up to four haploid products in the simplified model; actual gamete formation varies by organism and sex
Chromosome number	Usually maintained	Reduced by half in the transition from diploid to haploid
Genetic outcome	Usually preserves the parent cell's genome with possible new errors or changes	Produces genetically varied chromosome combinations

21.18 Errors in chromosome segregation

Nondisjunction occurs when chromosomes or sister chromatids fail to separate as expected. It can occur during mitosis or meiosis and may produce cells with abnormal chromosome numbers.

In meiosis, nondisjunction can produce gametes with an extra chromosome or a missing chromosome. After fertilization, this can result in aneuploidy. Examples include trisomy 21, which causes Down syndrome, and certain sex-chromosome aneuploidies.

The consequences depend on the chromosome involved, the extent of the abnormality, and the developmental context. Many severe chromosome abnormalities prevent normal embryonic development, while some are compatible with survival.

Errors during mitosis can produce populations of genetically distinct cells within one organism, a condition called mosaicism when different cell lineages have different genetic complements. Mosaicism can have varied effects depending on the cells involved and when the error occurs.

21.19 Cell division, tissue renewal, and cancer

Different tissues renew their cells at different rates. Some epithelial tissues replace cells frequently, while many neurons and highly specialized muscle cells generally do not undergo routine cell division in mature tissues.

Stem and progenitor cells support renewal in many tissues. Their divisions must be balanced with differentiation and cell loss so that the tissue maintains an appropriate number and type of cells.

Cancer can arise when genetic and epigenetic changes disrupt the control of proliferation, survival, genome integrity, or interactions with the surrounding tissue. Abnormal cell division is a central feature of many cancers, but cancer is not simply the result of cells dividing quickly: the ability to evade growth restraints, survive inappropriate conditions, and interact with the tissue environment also matters.

Key idea: The cell cycle coordinates DNA replication with cell division. Mitosis generally preserves chromosome number, while meiosis reduces chromosome number and generates genetic variation. Checkpoints and chromosome-segregation mechanisms reduce errors, but they do not eliminate all risk.

22. Differentiation, Stem Cells, Ageing, and Cell Death

Cells in the same organism can contain nearly the same genome yet look and behave very differently. A neuron transmits signals, a muscle cell generates force, a red blood cell transports oxygen, and a pancreatic beta cell secretes insulin. These differences arise through processes that regulate which genes are active, how proteins are produced, and how cellular structures are organized.

Cellular identity is not determined only by DNA sequence. It also depends on gene regulation, chromatin state, signalling history, interactions with neighbouring cells, metabolism, and the cell's developmental lineage.

22.1 What cellular differentiation means

Cellular differentiation is the process through which a cell acquires specialized characteristics. These characteristics may include a particular shape, set of proteins, metabolic profile, membrane properties, and biological function.

During development, relatively unspecialized cells receive and interpret signals that influence their developmental paths. Gene-regulatory networks then activate some genes while repressing others, producing a coordinated change in cellular identity.

For example, a muscle cell expresses proteins needed for contraction, while a neuron develops specialized processes and molecular machinery for electrical and chemical communication. Both cell types depend on general cellular processes, but their specialized functions require different patterns of gene expression.

Differentiation is often accompanied by changes in cell shape, organelle abundance, metabolism, and the proteins displayed on the cell surface. Some differentiated cells retain the ability to divide, while others become long-lived and rarely divide under normal conditions.

22.2 Gene expression and cellular identity

Gene expression is the process by which information encoded in genes is used to produce functional RNA and, for protein-coding genes, often proteins.

Cells regulate gene expression at several levels:

Transcriptional control: regulates when and how much RNA is produced from a gene.
RNA processing: affects how transcripts are spliced, modified, and prepared for use.
RNA stability: influences how long an RNA molecule remains available in the cell.
Translational control: regulates how efficiently RNA is used to make protein.
Protein modification and degradation: alter protein activity, location, interactions, and lifespan.

These controls allow cells to respond rapidly to changes while also maintaining longer-term patterns of specialization. A cell can change the activity of an existing protein quickly, whereas establishing a stable new cellular identity may require broader changes in gene expression and chromatin organization.

22.3 Transcription factors and gene-regulatory networks

Transcription factors are proteins that bind particular DNA sequences or participate in complexes that regulate transcription. They can promote or repress the transcription of target genes, often in combination with other regulatory proteins.

During differentiation, transcription factors operate in networks rather than as isolated switches. One factor may activate genes that reinforce a developmental programme, while also repressing genes associated with alternative cell identities.

Signals from outside the cell can influence these networks. Growth factors, developmental signalling molecules, hormones, and interactions with the extracellular matrix can all affect transcription-factor activity.

The resulting identity is maintained through a combination of active regulation, feedback, chromatin organization, and continued interactions with the cellular environment.

22.4 Epigenetics and chromatin

Epigenetics concerns changes in gene activity or cellular state that are not explained solely by changes in the DNA sequence. The term covers several mechanisms, including DNA methylation, histone modifications, and changes in chromatin organization.

In the nucleus, DNA is associated with histone proteins and other molecules to form chromatin. The organization of chromatin influences how accessible particular DNA regions are to transcription machinery and regulatory proteins.

Some epigenetic states can be maintained through cell division, helping daughter cells retain aspects of their identity. However, epigenetic states are not always permanent, and their stability varies by mechanism, cell type, and developmental context.

Epigenetics does not mean that DNA sequence is irrelevant or that experiences automatically rewrite the genome. It describes regulatory layers that influence how genetic information is used.

22.5 Potency: how many cell types can a cell produce?

Stem cells are often classified according to their developmental potential, or potency. These categories describe the range of cell types that a cell can generate under appropriate conditions.

Totipotent: can generate all embryonic cell types and the extraembryonic lineages needed for development of an entire organism, within the appropriate biological context.
Pluripotent: can generate cell types derived from all three embryonic germ layers, but does not normally produce an entire organism on its own because it lacks the full developmental potential of a totipotent cell.
Multipotent: can produce multiple related cell types within a more restricted developmental range.
Oligopotent: can produce a limited set of related cell types.
Unipotent: can produce one main differentiated cell type while retaining the ability to self-renew.

These terms describe developmental potential, not the rate at which a cell divides. A highly potent cell is not necessarily faster-growing than a more restricted progenitor.

22.6 Stem cells and self-renewal

Stem cells are defined by their capacity for self-renewal and their ability to produce differentiated progeny. The degree and type of differentiation they can support depend on the stem-cell population and its environment.

Self-renewal means that a cell division or series of divisions maintains a stem-cell population. It does not require every division to produce two identical stem cells. Depending on the system, stem cells may divide symmetrically or asymmetrically.

Symmetric self-renewal: produces two stem cells, increasing or maintaining the stem-cell pool.
Symmetric differentiation: produces two more differentiated progeny, reducing the stem-cell pool.
Asymmetric division: produces daughters with different fates, commonly one stem cell and one more differentiated cell.

These are useful conceptual categories. Real stem-cell behaviour can be more flexible, and the fate of daughter cells depends on intrinsic factors, cell interactions, and environmental signals.

22.7 Embryonic stem cells and induced pluripotent stem cells

Embryonic stem cells are pluripotent cells derived from the early embryo at a particular developmental stage. Under suitable laboratory conditions, they can self-renew and generate a wide range of differentiated cell types.

Induced pluripotent stem cells (iPSCs) are produced by reprogramming certain differentiated cells into a pluripotent-like state using defined regulatory factors and culture conditions.

iPSCs are important research tools because they can provide cell models derived from individual donors. Researchers can differentiate them into selected cell types to study disease mechanisms, investigate drug responses, and explore potential regenerative treatments.

However, pluripotency does not automatically make a cell safe or suitable for transplantation. Challenges include directing differentiation reliably, avoiding unwanted cell types, controlling genetic and epigenetic abnormalities, and ensuring that transplanted cells integrate and function appropriately.

22.8 Adult stem cells and tissue maintenance

Many adult tissues contain stem cells or progenitor cells that support maintenance and repair. Their potency is usually more restricted than that of pluripotent stem cells.

Blood-forming stem cells: hematopoietic stem cells in the bone marrow produce the lineages of blood cells.
Intestinal stem cells: maintain the intestinal epithelium, which undergoes continual renewal.
Skin stem and progenitor cells: contribute to the maintenance of the epidermis and associated structures.
Muscle satellite cells: can contribute to skeletal-muscle repair and regeneration after injury.

Adult stem cells operate within specialized microenvironments, often called niches. Signals from neighbouring cells, the extracellular matrix, and local conditions help regulate their survival, quiescence, division, and differentiation.

Not all tissues have the same regenerative capacity. Some can replace lost cells efficiently, while others recover poorly from substantial damage. Regeneration also varies with age, injury type, disease, and the structure of the tissue.

22.9 Cellular plasticity and reprogramming

Cellular identity is often stable, but it is not always irreversible. Under certain conditions, cells can change their state, activate different gene-regulatory programmes, or acquire features associated with another cell type.

Cellular plasticity refers broadly to the ability of cells to alter their state or behaviour. Reprogramming refers to processes that drive substantial changes in cell identity or developmental potential.

Researchers can reprogram differentiated cells into induced pluripotent stem cells, while some experimental approaches convert one differentiated cell type into another more directly. In living tissues, injury and disease can also alter cell states, although such changes may be incomplete or maladaptive.

Plasticity should not be interpreted as meaning that any cell can spontaneously become any other cell. The possibilities depend on the cell's existing regulatory state, genetic programme, and environmental conditions.

22.10 Cellular senescence

Cellular senescence is a state in which a cell undergoes a durable reduction or arrest in its ability to proliferate, often in response to stress, DNA damage, oncogene activation, or other signals.

Senescent cells are not necessarily inactive. They may remain metabolically active and produce signalling molecules, proteins, and enzymes that influence neighbouring cells and the extracellular matrix.

Senescence can be beneficial. It can help prevent the proliferation of cells with certain types of damage and contributes to some aspects of wound repair and tissue remodelling.

However, the accumulation of senescent cells or persistent production of inflammatory and matrix-modifying factors can contribute to tissue dysfunction in some contexts. The consequences depend on the cell type, the cause of senescence, and how long the state persists.

Senescence is distinct from quiescence. Quiescent cells are not actively proliferating but may be able to re-enter the cell cycle when appropriate signals arrive. Senescent cells typically have a more durable proliferation arrest, although the precise properties of senescence vary.

22.11 Why cells age

Cellular ageing is not caused by one universal mechanism. It reflects the accumulation and interaction of multiple changes, including damage to DNA and other molecules, altered protein maintenance, changes in mitochondrial function, epigenetic changes, and shifts in cellular signalling.

Important areas of research include:

DNA damage and mutation: DNA is continually exposed to internal and external sources of damage. Repair systems reduce the burden, but some changes persist.
Telomeres: chromosome ends contain specialized structures that help protect DNA. In many dividing cells, telomeres shorten over repeated divisions unless sufficient maintenance occurs.
Proteostasis: cells must synthesize, fold, repair, and remove proteins. Declining efficiency in these systems can contribute to the accumulation of abnormal proteins.
Mitochondrial changes: alterations in mitochondrial function can affect energy production, signalling, and cellular stress responses.
Epigenetic changes: patterns of gene regulation and chromatin organization can change over time.
Altered intercellular communication: signalling among cells and between tissues can change with age, influencing inflammation, repair, and metabolic regulation.

These mechanisms interact. It is inaccurate to describe ageing as simply the result of telomere shortening or free radicals alone. The relative importance of different mechanisms varies among tissues, organisms, and environmental conditions.

22.12 Telomeres and replicative limits

Telomeres are specialized DNA–protein structures at the ends of linear chromosomes. They help protect chromosome ends from being treated as broken DNA and contribute to the stability of the genome.

In many human somatic cells, telomeres tend to shorten over repeated divisions because of limitations in DNA replication and other processes. When telomeres become critically short or dysfunctional, they can activate DNA-damage responses and contribute to cell-cycle arrest or cell death.

Telomerase is an enzyme complex that can extend telomeric DNA. It is active in certain cell populations, including many germline cells and some stem-cell populations, and is often reactivated in cancers.

Telomere length is not a complete measure of biological age. Cells differ in telomerase activity, exposure to stress, DNA repair, and other aspects of maintenance. Some age-related changes occur without telomeres being the main limiting factor.

22.13 Apoptosis: programmed cell death

Apoptosis is a regulated form of cell death involving an organized sequence of molecular events. It is important in development, tissue maintenance, immune regulation, and the removal of cells that are damaged or no longer needed.

During typical apoptosis, a cell may shrink, chromatin condenses, DNA is fragmented, and the plasma membrane forms characteristic blebs. The cell is often divided into membrane-bound apoptotic bodies that can be engulfed by neighbouring cells or phagocytes.

Because apoptotic material is usually cleared efficiently, apoptosis often produces less inflammation than forms of cell death that involve extensive membrane rupture. However, the outcome depends on the circumstances and the effectiveness of clearance.

22.14 The intrinsic and extrinsic apoptotic pathways

Two major pathways can initiate apoptosis: the intrinsic pathway, which responds to internal cellular conditions, and the extrinsic pathway, which is initiated by particular external death signals.

The intrinsic pathway

The intrinsic pathway is closely associated with mitochondria and is often activated by severe DNA damage, growth-factor deprivation, or other forms of cellular stress.

Proteins of the BCL-2 family regulate mitochondrial outer-membrane permeabilization. When pro-apoptotic mechanisms dominate over protective mechanisms, mitochondrial proteins such as cytochrome c can be released into the cytosol.

Cytochrome c can help form a protein complex called the apoptosome, which activates initiator caspases and subsequently effector caspases. These enzymes cleave specific cellular proteins and coordinate the changes associated with apoptosis.

The extrinsic pathway

The extrinsic pathway begins when certain extracellular ligands bind to death receptors on the cell surface. These receptors assemble signalling complexes that can activate initiator caspases, which in turn activate downstream effector caspases.

Death-receptor signalling is important in immune regulation and the removal of certain unwanted or infected cells. The exact pathway and its consequences depend on the receptors and regulatory proteins present.

22.15 Caspases and the execution of apoptosis

Caspases are proteases that cleave specific protein targets. In apoptosis, initiator caspases activate downstream effector caspases, which dismantle selected cellular structures and regulatory systems.

Effector caspases can affect nuclear proteins, cytoskeletal components, and enzymes involved in maintaining DNA integrity. The result is an organized sequence of structural and biochemical changes that helps the cell disassemble.

Apoptosis is regulated rather than automatic. Cells contain inhibitors and survival pathways that can prevent inappropriate activation, and the outcome depends on the strength and combination of signals received.

22.16 Autophagy: recycling cellular components

Autophagy is a collection of processes through which cells deliver selected cytoplasmic material to lysosomes for degradation and recycling.

In macroautophagy, a membrane structure called a phagophore expands around cellular material and closes to form an autophagosome. The autophagosome then delivers its contents to the lysosomal system, where enzymes break them down.

Autophagy can help remove damaged organelles, recycle nutrients, and maintain cellular quality. Selective forms include mitophagy, which targets mitochondria, and other pathways that target particular structures or cargo.

Autophagy is not synonymous with apoptosis. Autophagy often supports cellular maintenance and survival, especially during nutrient stress, although its relationship with cell death is complex and context-dependent.

22.17 Necrosis and other regulated forms of cell death

Necrosis traditionally describes cell death associated with loss of membrane integrity, swelling, and breakdown of cellular structures. Severe physical injury, toxins, infection, or profound metabolic failure can produce necrotic damage.

Modern cell biology also recognizes regulated cell-death pathways that can produce necrotic features. These include necroptosis and pyroptosis, which involve distinct molecular mechanisms and can have important roles in inflammation and host defence.

Ferroptosis is another regulated form of cell death associated with iron-dependent lipid peroxidation and failure of protective systems that normally limit this damage.

These forms of cell death are not interchangeable. Their molecular mechanisms, triggers, and effects on neighbouring tissues differ. In particular, the inflammatory consequences depend on the pathway, the cellular context, and the clearance of dying cells.

22.18 Comparing apoptosis, autophagy, and necrotic cell death

Process	Primary meaning	Typical features
Apoptosis	Regulated cell-death programme	Caspase activation in many forms, cell shrinkage, DNA fragmentation, and organized clearance
Autophagy	Degradation and recycling of cellular material	Delivery of selected cytoplasmic cargo to lysosomes; often supports maintenance and survival
Necrosis	Cell death involving loss of structural integrity	May involve swelling, membrane rupture, release of cellular contents, and inflammation
Necroptosis	Regulated necrotic cell-death pathway	Uses specific signalling machinery and can cause membrane disruption
Pyroptosis	Inflammatory regulated cell death	Often associated with inflammatory caspases, gasdermin pores, and release of inflammatory signals
Ferroptosis	Iron-dependent regulated cell death	Associated with uncontrolled lipid peroxidation and failure of protective lipid-repair systems

This comparison is simplified. The molecular pathways involved in cell death overlap in some contexts, and researchers continue to refine how particular forms are defined and distinguished.

22.19 How cells decide between survival, arrest, and death

A cell's response to stress depends on the type and severity of the disturbance, the duration of exposure, the cell's developmental state, and the pathways available to it.

For example, limited DNA damage may trigger repair and allow the cell cycle to continue. More persistent damage may lead to senescence or apoptosis. Severe loss of energy production can disrupt ion gradients and membrane integrity, potentially causing forms of cell death associated with extensive cellular damage.

These outcomes are not determined by one universal threshold. They arise from interacting signalling networks that integrate damage responses, metabolism, survival signals, and cell-type-specific regulatory mechanisms.

22.20 Cellular turnover and the health of tissues

Tissue maintenance depends on balancing cell production, differentiation, function, and removal. In tissues with high turnover, stem and progenitor cells continually replace cells that are shed or lost. In other tissues, long-lived cells are maintained for extended periods and rely heavily on repair and quality-control systems.

Too little cell death can allow damaged or abnormal cells to persist. Too much cell death can destroy functional tissue. Likewise, excessive proliferation can disrupt tissue organization, while inadequate proliferation can impair repair.

Healthy tissue maintenance therefore requires coordination among cell division, differentiation, metabolism, intercellular signalling, and regulated cell removal.

Key idea: Cellular identity is maintained through gene regulation and interactions with the environment. Stem cells support renewal, senescence limits proliferation in certain conditions, and multiple cell-death pathways help remove cells when appropriate. These processes are essential for development, repair, and long-term tissue function.

23. Cancer and Loss of Cellular Control

Cancer is a group of diseases in which cells acquire changes that allow abnormal growth, survival, invasion, or spread. Cancer is not a single disease, and it is not caused by one universal mutation. Different cancers arise in different tissues, involve different molecular changes, and respond differently to treatment.

At the cellular level, cancer develops when the normal mechanisms controlling cell division, survival, differentiation, DNA integrity, and interactions with neighbouring cells become disrupted. These changes can allow a population of cells to expand when it should not, survive when damaged, invade surrounding tissues, or establish new growths in distant organs.

Cancer development often involves a combination of genetic changes, epigenetic alterations, environmental exposures, inherited susceptibility, and interactions between abnormal cells and their surrounding tissue. The importance of each factor varies among cancer types and individuals.

23.1 What distinguishes a cancer cell from a normal cell?

Normal cells do not divide continuously under all conditions. Their behaviour is regulated by growth factors, nutrients, contact with neighbouring cells, signals from the extracellular matrix, and mechanisms that detect cellular damage.

When a normal cell experiences DNA damage, it may stop progressing through the cell cycle, attempt repair, enter a durable growth-arrest state, or undergo programmed cell death. These responses help prevent damaged cells from reproducing uncontrollably.

Cancer cells may acquire changes that weaken or bypass one or more of these controls. Depending on the cancer, they may:

Produce or respond excessively to growth-promoting signals.
Ignore signals that normally limit cell proliferation.
Continue dividing despite certain forms of DNA damage.
Avoid apoptosis or other forms of cell death.
Alter their metabolism to support continued growth.
Change their interactions with neighbouring cells and the extracellular matrix.
Recruit blood vessels to support an expanding tumour.
Evade or suppress aspects of the immune response.
Invade surrounding tissues and, in malignant cancers, potentially spread to distant sites.

These are broad characteristics rather than a checklist that every cancer must satisfy. Some cancers grow slowly, some are aggressive, and some remain localized for long periods. Cancer behaviour depends on the combination of molecular changes, tissue context, immune interactions, and other factors.

23.2 Benign tumours and malignant tumours

A tumour is an abnormal mass of tissue. Tumours can be benign or malignant, and not every abnormal growth is cancer.

Benign tumour: an abnormal growth that does not invade surrounding tissues or metastasize. Benign tumours can nevertheless cause harm if they compress important structures, obstruct an organ, or produce biologically active substances.
Malignant tumour: a cancerous growth capable of invading surrounding tissue. Some malignant tumours can also spread to distant sites.
Metastatic tumour: a tumour formed when cancer cells spread from their original site and establish growth elsewhere.

The term carcinoma generally refers to a cancer derived from epithelial cells. Sarcomas arise from mesenchymal tissues, such as bone, muscle, or connective tissue. Blood-forming and lymphoid malignancies include leukaemias and lymphomas. These categories differ in their cellular origins, patterns of growth, and usual treatment approaches.

Classification matters because two tumours that appear similar under a microscope may have different molecular drivers and clinical behaviour. Conversely, tumours arising in different locations may share molecular changes that influence treatment.

23.3 Cancer is a multistep evolutionary process

Cancer often develops through the accumulation of changes over time. A cell may acquire a mutation that gives it a small growth or survival advantage. Its descendants can become more numerous, increasing the number of cells in which additional changes may arise.

Within a tumour, cells are not necessarily genetically identical. As cells divide, mutations and other changes can produce subpopulations with different properties. This variation creates opportunities for selection: cells with characteristics that support survival and expansion under local conditions may become more common.

This process resembles evolution by variation and selection, but it occurs within the tissues of an individual organism. Selection pressures may include nutrient availability, oxygen levels, immune attack, competition with other cells, and exposure to treatment.

A treatment may eliminate a large proportion of tumour cells while leaving a small population with resistance-associated properties. If these surviving cells expand, the cancer may recur or progress. Resistance can arise through pre-existing variation or through changes acquired during tumour evolution.

Not every mutation contributes to cancer progression. Some mutations are driver mutations because they provide a growth or survival advantage in a particular context. Others are passenger mutations that accumulate without directly driving the tumour's behaviour.

23.4 Proto-oncogenes and oncogenes

Oncogenes are altered or abnormally activated genes that can promote cancer development. Many originate from normal genes called proto-oncogenes, which have important roles in regulating cell growth, division, differentiation, and survival.

Normal cells need growth-promoting genes. The problem arises when their activity becomes excessive, poorly regulated, or active in the wrong circumstances.

Oncogene activation can occur through several mechanisms:

Point mutation: a change in DNA sequence can produce a protein that is excessively active or no longer regulated normally.
Gene amplification: additional copies of a gene can increase the amount of its protein product.
Chromosomal rearrangement: DNA segments can be rearranged, placing a gene under a different regulatory system or producing a fusion gene.
Abnormal gene regulation: regulatory changes can cause excessive or inappropriate gene expression.

Oncogenes frequently act through growth-factor signalling pathways, intracellular signalling proteins, transcription factors, or proteins that regulate cell survival.

Example: RAS signalling

RAS proteins are small GTP-binding proteins involved in transmitting signals from cell-surface receptors to intracellular pathways that regulate growth and survival. Their activity normally cycles between different molecular states.

Certain mutations in RAS genes can impair normal inactivation, allowing signalling to remain abnormally active. Such changes can help cells proliferate even when ordinary growth controls would restrict them.

RAS alterations occur in several cancer types, although their frequency and biological significance vary. The effect of a mutation also depends on other changes within the cell.

Example: growth-factor receptors

Some cancers have excessive activity of receptor proteins that normally respond to growth factors. This can result from increased receptor abundance, gene amplification, mutations, or other regulatory changes.

When a growth-signalling pathway becomes abnormally active, a cell may receive stronger or more persistent instructions to divide. Some targeted therapies work by inhibiting particular receptors or the downstream proteins that carry their signals.

23.5 Tumour-suppressor genes

Tumour-suppressor genes help prevent inappropriate cell growth, preserve genomic stability, or promote the removal of damaged cells.

Whereas oncogene activation can promote cancer, loss of tumour-suppressor function can remove restraints that normally limit cell proliferation or protect the genome.

Tumour-suppressor proteins can perform several kinds of function:

Detect DNA damage and coordinate cell-cycle arrest.
Regulate whether a cell can progress into DNA replication.
Promote DNA repair or other protective responses.
Activate cell death when damage is too severe.
Regulate cell adhesion, polarity, differentiation, or tissue organization.
Maintain chromosome stability and appropriate cellular behaviour.

In many cases, both copies of a tumour-suppressor gene must be inactivated or significantly impaired for the cell to lose the relevant protective function. This is a useful general model, but it is not universal: the consequences of some alterations depend on dosage, the specific mutation, and interactions with other proteins.

Example: TP53

The TP53 gene encodes p53, a protein that responds to several forms of cellular stress, including certain kinds of DNA damage. Depending on the context, p53 can promote cell-cycle arrest, influence DNA repair, trigger senescence, or contribute to apoptosis.

When p53 function is disrupted, a cell may become less able to respond appropriately to particular types of damage. This can allow abnormal cells to survive and divide, increasing the opportunity for additional changes to accumulate.

TP53 alterations are common in many cancers, but p53 does not operate alone. Its effects depend on the wider regulatory network and the biological condition of the cell.

Example: RB and cell-cycle control

The RB protein, encoded by the RB1 gene, helps regulate the transition from G1 into S phase. It influences transcription factors that control the expression of genes required for DNA replication.

When RB-mediated control is functioning properly, entry into DNA replication depends on appropriate signals. Loss of RB function can weaken this restraint and contribute to inappropriate cell-cycle progression.

RB illustrates an important principle: cancer can result not only from excessive activation of growth-promoting signals, but also from the loss of systems that normally limit those signals.

23.6 DNA damage, mutations, and cancer

DNA is continually exposed to chemical reactions inside the cell, errors during replication, and environmental agents. Cells have multiple DNA-repair systems, but repair is not perfect.

A DNA lesion is a form of DNA damage or abnormality. A mutation is a change in the DNA sequence. Some lesions are repaired accurately, some can be repaired incorrectly, and some can lead to mutations if they persist through replication.

Mutations can affect protein-coding sequences, regulatory DNA, splice sites, or other genomic regions. Their consequences depend on where they occur and how they affect gene function or regulation.

DNA changes relevant to cancer can include:

Single-nucleotide substitutions.
Insertions or deletions of DNA bases.
Large chromosomal deletions or duplications.
Chromosomal rearrangements.
Changes in the number of chromosomes.
Alterations that change the expression of genes without changing their protein-coding sequence.

Mutations do not automatically cause cancer. Most mutations do not provide a selective advantage, and many cells with serious damage stop dividing or die. Cancer risk rises when changes affect important growth-control systems and persist in cells capable of continued proliferation.

23.7 DNA-repair pathways and genomic stability

DNA repair comprises several systems that recognize and correct different kinds of DNA damage. No single repair pathway can handle every possible lesion.

Mismatch repair: corrects many errors introduced during DNA replication, including incorrectly paired bases and small insertion–deletion loops.
Base-excision repair: removes and replaces damaged or inappropriate individual DNA bases and repairs associated small lesions.
Nucleotide-excision repair: removes certain bulky DNA lesions that distort the DNA helix.
Homologous recombination: repairs particular forms of DNA double-strand break using a homologous DNA template.
Non-homologous end joining: rejoins broken DNA ends through a pathway that does not require an extensive homologous template; the repair can sometimes introduce sequence changes.

Repair defects can increase the rate at which mutations or chromosome abnormalities accumulate. For example, inherited or acquired defects in particular DNA-repair genes can raise the risk of specific cancer types.

However, DNA repair is only one part of cancer prevention. Cell-cycle checkpoints, apoptosis, immune surveillance, and tissue organization also help limit the persistence and expansion of abnormal cells.

23.8 Inherited susceptibility and acquired mutations

Some people inherit a genetic variant that increases their susceptibility to particular cancers. Inherited susceptibility does not mean that cancer is inevitable. It means that a biological risk factor is present from the beginning of life and can change the probability of disease under particular circumstances.

Other mutations arise during a person's lifetime. They may result from normal DNA replication, endogenous chemical reactions, environmental exposures, or other processes. These acquired changes are often called somatic mutations when they occur in non-germline cells.

For many cancers, both inherited factors and acquired changes can contribute, but their relative importance differs. A family history of cancer can reflect inherited variants, shared exposures, chance, or combinations of these factors.

Genetic testing can be useful in selected situations, but the meaning of a result depends on the particular variant, the person's history, and the clinical question. A genetic variant associated with increased risk is not equivalent to a diagnosis of cancer.

23.9 Epigenetic changes in cancer

Cancer cells can develop abnormal patterns of gene regulation without changing the DNA sequence of every affected gene. These changes can involve DNA methylation, histone modifications, chromatin organization, and regulatory RNAs.

Epigenetic alterations can contribute to cancer by reducing the expression of protective genes, changing differentiation programmes, or increasing the activity of genes that support tumour growth.

For example, abnormal silencing of a tumour-suppressor gene can weaken a protective pathway even when its coding sequence remains intact. Conversely, changes that increase the expression of a growth-promoting gene can contribute to inappropriate signalling.

Epigenetic changes are not always permanent, and their relationship with cancer is complex. They can be early contributors to tumour development, consequences of other cellular changes, or features that help particular tumour-cell populations adapt.

23.10 Why cancer cells can avoid cell death

Normal cells have several mechanisms that limit survival when their condition becomes incompatible with healthy function. Apoptosis is one of these mechanisms, but it is not the only one.

Cancer cells can acquire changes that weaken cell-death signalling, increase the activity of survival pathways, or alter the proteins that regulate mitochondrial responses to stress.

Some cancer cells also develop resistance to particular treatments that rely on DNA damage or activation of cell-death pathways. Resistance may involve changes in the treatment target, improved handling of damage, altered drug transport, or changes in the balance of survival and death signals.

Resistance does not mean that a cancer cell is invulnerable. It means that a particular mechanism of control or treatment is less effective under the conditions involved. Other vulnerabilities may remain.

23.11 Tumour metabolism

Growing tumours need energy and the molecular building blocks required to make DNA, RNA, proteins, membranes, and other cellular components. Cancer cells can alter how they acquire and use nutrients.

Many cancer cells show increased glucose uptake and substantial conversion of glucose to lactate even when oxygen is available. This pattern is often called the Warburg effect or aerobic glycolysis.

The Warburg effect does not mean that all cancer cells stop using mitochondria. Many cancers continue to use mitochondrial metabolism, and the relative contributions of glycolysis, oxidative phosphorylation, and other pathways vary by tumour type and environment.

Altered metabolism can help support rapid growth, maintain redox balance, and provide intermediates for biosynthesis. However, metabolic changes are diverse, and no single metabolic pattern is shared by every cancer.

Because tumours depend on specific metabolic activities in particular contexts, metabolism is an area of cancer research. Turning a metabolic difference into an effective treatment can be challenging because normal cells often rely on the same pathways.

23.12 Angiogenesis: supplying the tumour

Angiogenesis is the formation of new blood vessels from existing vessels. It is important in normal development, wound repair, and other physiological processes.

As a tumour grows, the cells inside it may experience reduced oxygen and nutrient availability. In some tumours, these conditions promote the release of signals that encourage nearby blood vessels to grow toward the tumour.

One important signalling molecule is vascular endothelial growth factor, commonly abbreviated VEGF. VEGF-related signalling can promote endothelial-cell responses that support blood-vessel formation.

Tumour blood vessels are often structurally and functionally abnormal. They may be disorganized, unusually permeable, and inefficient at delivering oxygen uniformly. Consequently, a tumour can contain regions with very different levels of oxygen, nutrients, acidity, and drug exposure.

These local conditions can influence tumour-cell behaviour and treatment response. Anti-angiogenic therapies attempt to interfere with selected vessel-growth pathways, but their effects depend on the cancer, treatment strategy, and surrounding tissue.

23.13 The tumour microenvironment

A tumour is not composed exclusively of cancer cells. It can also contain blood vessels, immune cells, fibroblasts, extracellular matrix, and other components of the surrounding tissue.

This collection of cells and non-cellular material is often called the tumour microenvironment. Its components exchange chemical signals and influence one another's behaviour.

Fibroblasts may alter the extracellular matrix and produce signalling molecules. Immune cells may attack cancer cells, support tissue repair, or become functionally suppressed. Blood vessels affect nutrient delivery and cell movement, while the extracellular matrix influences attachment, mechanical forces, and migration.

The microenvironment can therefore promote or restrain tumour growth. Its effects depend on the cancer type, the stage of disease, the immune context, and the particular cell populations involved.

23.14 Invasion and metastasis

Metastasis occurs when cancer cells spread from their original site and establish growth in distant tissues. It is a multistep process rather than a single event.

In a simplified description, metastatic spread may involve:

Changes that allow cancer cells to move away from the primary tumour.
Local invasion through or around surrounding tissue structures.
Entry into blood vessels or lymphatic vessels, a process called intravasation.
Survival while travelling through the circulation.
Exit from a vessel into another tissue, called extravasation.
Survival and adaptation within the new tissue environment.
Establishment and expansion of a secondary tumour.

Not every cancer cell that enters the circulation successfully forms a metastasis. Many cells die, are eliminated, or fail to adapt to the new environment. Successful metastasis requires a combination of cellular properties and favourable conditions in the destination tissue.

The ability to invade and metastasize is one of the major features distinguishing malignant cancer from a benign tumour. However, the likelihood and pattern of spread vary greatly among cancers.

23.15 Epithelial-to-mesenchymal transition and cell plasticity

Some cancer cells undergo changes that resemble aspects of epithelial-to-mesenchymal transition, often abbreviated EMT. During this process, epithelial cells can alter their cell–cell adhesion, polarity, shape, and interactions with the extracellular matrix.

These changes can be associated with increased motility and invasion in particular contexts. EMT-related programmes are also involved in normal development and wound repair.

Cancer-cell plasticity is complex. Some tumour cells show partial EMT states rather than a complete conversion from one cell identity to another. Metastasis can involve multiple cellular strategies, and EMT is not required in the same way for every cancer.

After reaching a distant site, some cells may also acquire properties that support renewed growth or a more epithelial-like organization. The relationship between cell identity, movement, and metastatic success depends on the tumour and its environment.

23.16 Immune surveillance and cancer immune evasion

The immune system can recognize and eliminate some abnormal cells, including certain cancer cells. This protective activity is often discussed under the concept of cancer immunosurveillance.

Cancer cells may nevertheless persist by changing the molecules they display, reducing the visibility of tumour-associated antigens, creating an immunosuppressive environment, or engaging inhibitory pathways that limit immune-cell activity.

Some tumours contain T cells that recognize tumour-associated targets but do not eliminate the cancer effectively. Their activity may be restricted by inhibitory receptors, suppressive cells, metabolic limitations, or other features of the tumour microenvironment.

Immune evasion is not absolute. The immune system can still exert pressure on a tumour, and some cancers respond well to immunotherapies that restore or redirect particular immune functions.

23.17 Cancer grading and staging

Cancer grade and stage describe different aspects of disease.

Grade: describes features of the cancer cells and tissue, often including how abnormal the cells look and how much they resemble the normal tissue from which they arose.
Stage: describes the extent of the cancer in the body, including the size or local extent of the primary tumour, involvement of regional lymph nodes, and presence or absence of distant metastasis.

High-grade cancers often show more abnormal cellular features and may behave more aggressively, but grading systems differ among cancer types. Stage is also strongly related to prognosis, although the relationship varies by disease and treatment.

Many solid cancers use some version of the TNM framework: tumour, regional lymph nodes, and distant metastasis. Not every cancer is staged using the same system, and blood cancers often require different classification approaches.

Grade and stage are important for treatment planning, but they do not determine every outcome. Molecular characteristics, patient circumstances, treatment response, and other clinical factors also matter.

23.18 How cancer treatments exploit cell biology

Cancer treatments work through different mechanisms. Their selection depends on the cancer type, stage, molecular characteristics, prior treatment, and the person's overall circumstances.

Surgery

Surgery removes a tumour or affected tissue when the disease's location and extent make this appropriate. It may be used alone or combined with other treatments. Surgery does not necessarily eliminate cancer cells that have already spread beyond the removed tissue.

Radiation therapy

Radiation therapy delivers ionizing radiation to damage cellular DNA and other molecules. The resulting damage can prevent tumour cells from reproducing or trigger cell death. Treatment planning aims to deliver an effective dose to the target while limiting damage to nearby healthy tissue.

Chemotherapy

Many chemotherapy drugs interfere with DNA replication, DNA integrity, cell division, or other processes required for cell survival. Some drugs affect rapidly dividing cells more strongly, but their effects are not limited exclusively to cancer cells.

This helps explain why some chemotherapy treatments can also affect normal tissues that renew frequently, including hair follicles, bone marrow, and the lining of the digestive tract.

Targeted therapy

Targeted therapies act on particular molecular features that contribute to cancer growth or survival. Examples include inhibitors of selected growth-factor receptors or signalling proteins.

Such therapies can be effective when the relevant target is an important driver of the cancer. However, tumours can develop resistance, and the same target may not be important in every cancer of the same organ.

Hormone therapy

Some cancers depend partly on hormonal signalling. Hormone therapies can reduce hormone production, block hormone receptors, or otherwise interfere with the relevant signalling pathway.

These treatments are used in selected cancers, including particular forms of breast and prostate cancer. Their effectiveness depends on the tumour's hormone responsiveness and other biological characteristics.

Immunotherapy

Immunotherapy aims to use or modify immune-system activity to help control cancer. Some treatments block inhibitory immune checkpoints, while others use engineered immune cells, antibodies, or other immune-directed approaches.

Immune treatments do not work equally well for every cancer. Their effects depend on tumour biology, immune recognition, the microenvironment, and other factors. They can also cause inflammatory or immune-related adverse effects.

23.19 Why cancer can return after treatment

A cancer can recur when surviving cells remain after treatment and later resume growth. Recurrence may occur locally, in nearby tissues, or at distant sites, depending on the disease and treatment.

Several mechanisms can contribute:

Some tumour cells may survive because they were not fully exposed to the treatment.
Different tumour-cell populations may have different sensitivities to the same drug or radiation dose.
Cells may carry or acquire changes that reduce treatment effectiveness.
Some cells may enter relatively slow-growing or dormant states that make particular treatments less effective.
The tissue environment may protect some tumour cells or influence their ability to recover.

Recurrence does not necessarily mean that the original treatment was inappropriate or that every cancer cell was resistant from the beginning. It reflects the difficulty of eliminating all malignant cells in some clinical situations.

23.20 Cancer prevention and risk reduction

Cancer risk is influenced by age, inherited susceptibility, environmental exposures, infections, hormones, and many other factors. No prevention strategy eliminates all risk, but some measures reduce the likelihood of particular cancers.

Examples include avoiding tobacco, limiting harmful ultraviolet exposure, receiving recommended vaccinations against cancer-associated infections, reducing exposure to certain occupational carcinogens, and participating in screening programmes when appropriate.

Screening aims to detect selected cancers or precancerous changes before symptoms develop or while treatment may be more effective. The usefulness of a screening test depends on the person's age and risk profile, the disease being screened for, and the balance of benefits and harms.

Not every cancer is preventable, and developing cancer does not mean that a person made an incorrect lifestyle choice. Many cases arise through a complex combination of biological processes and risk factors that cannot be fully controlled.

Key idea: Cancer emerges when multiple systems that regulate cell growth, survival, genome integrity, and tissue interactions become disrupted. Tumours evolve through variation and selection, interact with their microenvironment, and may develop resistance to treatment. Understanding these cellular mechanisms explains both the diversity of cancer and the need for treatment strategies tailored to the particular disease.

24. Cells in Immunity and Inflammation

The immune system protects the body against infectious agents and helps manage damaged or abnormal cells. It does this through coordinated activity among specialized immune cells, tissue cells, blood vessels, signalling molecules, and barrier structures.

Immune defence is not simply a matter of identifying something foreign and destroying it. The immune system must distinguish threats from normal tissue, select an appropriate response, control the intensity of that response, and help restore tissue function afterward.

Too little immune activity can allow infections or abnormal cells to persist. Excessive or misdirected immune activity can damage healthy tissues. Immune regulation is therefore as important as immune activation.

24.1 Innate and adaptive immunity

The immune system is often divided into innate immunity and adaptive immunity. These are interacting systems rather than completely separate processes.

Innate immunity provides rapid responses using barriers, soluble molecules, and cells that recognize broad classes of danger-associated patterns. It includes the skin, mucosal barriers, complement proteins, neutrophils, macrophages, dendritic cells, natural killer cells, and other components.

Adaptive immunity uses B and T lymphocytes with highly specific antigen receptors. It can produce targeted responses against particular antigens and, in many cases, generate immunological memory that improves responses to later encounters.

Innate immune cells help initiate and shape adaptive responses. Adaptive immune cells, in turn, can direct innate cells and enhance their ability to eliminate particular threats.

Feature	Innate immunity	Adaptive immunity
Recognition	Uses receptors that recognize broad molecular patterns and selected danger signals	Uses highly diverse antigen receptors on B and T lymphocytes
Initial response	Often rapid	Primary responses generally require time for activation and expansion
Major cellular participants	Neutrophils, macrophages, dendritic cells, natural killer cells, and others	B lymphocytes and T lymphocytes
Memory	Some forms of innate immune training occur, but this differs from classical adaptive memory	Memory B and T cells can support stronger or faster responses to later encounters
Relationship	Helps initiate and direct adaptive responses	Can enhance and regulate innate immune activity

24.2 Physical and chemical barriers

The first line of defence includes structures and conditions that make it more difficult for pathogens to enter or persist in the body.

Skin: forms a physical barrier, while its surface conditions and resident microorganisms influence microbial growth.
Mucosal surfaces: line regions such as the respiratory and digestive tracts and provide protective secretions and specialized cells.
Mucus and cilia: in parts of the respiratory tract, mucus traps particles and microorganisms, while coordinated ciliary movement helps move material out of the airways.
Digestive conditions: stomach acidity, digestive enzymes, bile, and other factors influence which organisms survive the gastrointestinal environment.
Antimicrobial molecules: substances such as lysozyme and defensins can damage or inhibit certain microbes.
Normal microbiota: resident microorganisms can compete with pathogens and influence the development and activity of the immune system.

These barriers do not make infection impossible. Pathogens differ in their ability to survive, attach to tissues, enter cells, or avoid host defences. When a barrier is damaged or bypassed, additional immune mechanisms may be required.

24.3 How innate immune cells recognize danger

Innate immune cells use pattern-recognition receptors to detect molecular features associated with microbes or cellular damage. These receptors recognize classes of molecules rather than every possible antigen individually.

Examples of receptors include Toll-like receptors, NOD-like receptors, and other sensing systems located on cell surfaces, inside cellular compartments, or in the cytoplasm.

Microbial molecules can include components of bacterial cell walls, nucleic acids from particular pathogens, or other structures associated with infection. Damaged or stressed host cells can also release molecules that activate certain danger-sensing pathways.

Receptor activation can lead to changes in gene expression, production of cytokines, increased antimicrobial activity, and recruitment of additional immune cells.

Recognition is context-dependent. A receptor's presence does not guarantee that a full inflammatory response will occur; the response depends on signal strength, cellular state, regulatory pathways, and interactions with other signals.

24.4 Neutrophils: rapid responders

Neutrophils are abundant white blood cells that often arrive early at sites of acute infection or tissue injury. They are especially important in responses to many bacteria and fungi.

Neutrophils can move through blood-vessel walls into tissues, follow chemical signals, engulf microbes, and use several mechanisms to kill or restrict them.

Important neutrophil functions include:

Phagocytosis: engulfing microorganisms or particles into internal compartments.
Granule release: delivering antimicrobial proteins and enzymes to appropriate locations.
Reactive oxygen species: generating chemically reactive molecules that contribute to microbial killing.
Extracellular traps: releasing networks of DNA and associated proteins in certain circumstances that can capture microbes.

Neutrophils can also contribute to tissue injury. Their enzymes and reactive molecules are useful for antimicrobial defence but can damage surrounding host tissue when released inappropriately or in excessive amounts.

Neutrophils are generally short-lived compared with many other cell types, particularly in inflamed tissues. Their recruitment, activation, and removal must be coordinated to resolve inflammation.

24.5 Monocytes and macrophages

Monocytes circulate in the blood and can enter tissues, where some differentiate into macrophage-like or other specialized populations.

Macrophages are phagocytic cells with important roles in microbial defence, removal of dead cells, tissue maintenance, immune signalling, and repair.

Macrophages can engulf microbes and debris into membrane-bound compartments. These compartments can mature and interact with lysosomes, exposing the engulfed material to acidic conditions, digestive enzymes, and other antimicrobial mechanisms.

Macrophages also release cytokines and chemokines that influence other immune cells. Depending on their location and signals, they can promote inflammation, help resolve it, support repair, or perform specialized tissue-maintenance functions.

Macrophages are highly diverse. Tissue-resident populations in organs such as the brain, liver, lungs, and skin can have distinct origins and specialized roles. It is therefore misleading to treat all macrophages as one uniform cell type.

24.6 Dendritic cells and antigen presentation

Dendritic cells are important antigen-presenting cells that connect innate recognition with adaptive immunity.

They can capture material in tissues, process proteins into smaller peptide fragments, and display selected peptides on major histocompatibility complex molecules. After receiving appropriate activation signals, dendritic cells can migrate to lymphoid tissues and interact with T lymphocytes.

Activation of a naïve T cell generally requires more than the recognition of a peptide alone. T-cell receptor engagement, co-stimulatory signals, and the surrounding cytokine environment help determine whether and how the T cell responds.

This multi-signal system helps reduce inappropriate activation against harmless or self-derived material. It also allows dendritic cells to influence the type of adaptive response that develops.

Dendritic cells are not the only cells capable of presenting antigens, but they are especially important for initiating many primary T-cell responses.

24.7 Antigens and antibodies

An antigen is a molecule or molecular structure that can be specifically recognized by an antibody, B-cell receptor, T-cell receptor, or another immune recognition system. Not every antigen triggers a strong immune response under every condition.

Antibodies, also called immunoglobulins, are proteins produced by differentiated B cells called plasma cells. Each antibody has regions that bind particular molecular structures.

Antibodies can help protect the body in several ways:

Neutralization: binding to a virus, toxin, or other target in a way that blocks its ability to interact with cells or carry out a harmful function.
Opsonization: coating a target so that phagocytic cells can recognize and engulf it more efficiently.
Complement activation: initiating or enhancing particular complement pathways, depending on the antibody class and context.
Agglutination: cross-linking particles or cells, which can help organize targets for removal.

Antibodies do not directly destroy every target they bind. Their effects depend on antibody class, target accessibility, affinity, the surrounding environment, and the availability of immune mechanisms that can act on the bound target.

24.8 B lymphocytes and plasma cells

B lymphocytes are adaptive immune cells that recognize antigens through B-cell receptors. When appropriately activated, some B cells proliferate and differentiate into antibody-secreting plasma cells.

Many B-cell responses involve help from specialized CD4-positive T cells. The interaction can support B-cell proliferation, antibody class switching, affinity maturation, and the development of memory B cells.

Class switching changes the antibody class produced by a B cell while generally preserving the antigen specificity determined by its variable regions. This allows antibodies to perform different functions in different biological settings.

Affinity maturation occurs through mutation and selection processes in germinal centres, structures found in certain lymphoid tissues. B-cell populations whose receptors bind antigen more effectively can be preferentially selected under suitable conditions.

Some activated B cells become long-lived plasma cells, while others become memory B cells. These populations help maintain antibody production or support faster responses during later encounters with the same or related antigen.

24.9 T lymphocytes

T lymphocytes recognize antigens through T-cell receptors. In conventional T cells, the receptor recognizes a peptide presented by a major histocompatibility complex molecule rather than usually binding a free intact protein in the same way an antibody can.

Two major categories of conventional T cells are CD4-positive helper T cells and CD8-positive cytotoxic T cells. These categories have different but interacting functions.

CD4-positive helper T cells

Helper T cells coordinate immune responses through cytokines and direct interactions with other cells. Different helper-cell states can support different functions, including assistance to B cells, recruitment and activation of other immune cells, and regulation of responses at barrier tissues.

Regulatory T cells are a specialized population that helps limit inappropriate or excessive immune activity and contributes to immune tolerance.

CD8-positive cytotoxic T cells

Cytotoxic T cells can recognize target cells displaying appropriate peptide–MHC class I complexes. Once activated, they can kill infected or abnormal cells through mechanisms that include delivery of cytotoxic granule proteins and activation of death-receptor pathways.

Cytotoxic T cells do not attack every cell that contains foreign material. Recognition depends on antigen presentation, receptor specificity, activation state, and additional regulatory signals.

24.10 Natural killer cells

Natural killer cells, often abbreviated NK cells, are innate lymphocytes involved in responses against certain infected, stressed, or transformed cells.

NK cells integrate signals from activating and inhibitory receptors. Some inhibitory receptors recognize normal self-MHC class I molecules, which can help restrain inappropriate killing of healthy cells.

When the balance of signals favours activation, NK cells can release cytotoxic granules containing proteins that help damage the target cell and trigger cell death. They can also produce cytokines that influence other immune cells.

NK cells differ from conventional T cells in how they recognize targets. They do not rely on the same type of highly specific rearranged T-cell receptor, although their responses can still be shaped by prior exposure and other forms of regulation.

24.11 Major histocompatibility complex and antigen presentation

Major histocompatibility complex (MHC) molecules display peptide fragments for recognition by T cells. In humans, these molecules are commonly called human leukocyte antigens, or HLA.

MHC class I molecules are expressed by most nucleated cells. They generally present peptides derived from proteins produced inside the cell, allowing CD8-positive T cells to inspect aspects of intracellular protein production.

MHC class II molecules are expressed mainly by professional antigen-presenting cells, including dendritic cells, macrophages, and B cells. They commonly present peptides derived from material taken up from outside the cell and processed through intracellular compartments.

This distinction is a useful general model, but antigen-presentation pathways include additional mechanisms and exceptions. For example, dendritic cells can present some externally acquired antigens through MHC class I pathways, a process known as cross-presentation.

24.12 Cytokines and chemokines

Cytokines are signalling proteins that influence the behaviour of immune cells and many other cell types. They can regulate activation, proliferation, differentiation, survival, inflammation, and tissue repair.

Chemokines are a group of signalling proteins that help guide the movement of cells. They can create chemical cues that influence where immune cells travel and accumulate.

Some cytokines promote inflammation, while others limit it or support tissue recovery. The same cytokine can have different effects depending on the target cell, receptor expression, timing, concentration, and local environment.

Examples include:

Interleukins: a broad family of cytokines involved in immune-cell communication and regulation.
Interferons: signalling proteins with important roles in antiviral defence and other immune responses.
Tumour necrosis factor (TNF): a cytokine involved in inflammation, immune regulation, and several cell-survival or cell-death pathways.
Interleukin-1: a mediator involved in inflammatory responses and fever.
Interleukin-10: an important regulatory cytokine that can limit aspects of inflammatory activity.
Chemokines: guide immune-cell movement through tissues and toward sites of infection or injury.

Cytokines form interconnected networks rather than isolated signals. Excessive or poorly regulated cytokine activity can contribute to tissue damage, while insufficient signalling can impair host defence.

24.13 Inflammation: the coordinated tissue response

Inflammation is a coordinated response to infection, tissue damage, and certain forms of irritation or cellular stress. It involves immune cells, blood vessels, signalling molecules, and changes in the surrounding tissue.

Common signs of acute inflammation include redness, heat, swelling, pain, and reduced function. These features arise through combinations of increased blood flow, changes in vascular permeability, accumulation of fluid, and activation of sensory and tissue pathways.

Inflammation can be protective because it helps bring immune cells and defensive molecules to a site where they are needed. It also supports the removal of damaged material and the initiation of repair.

However, inflammation can damage healthy tissue when it is excessive, prolonged, or directed against inappropriate targets. The consequences depend on the trigger, the tissue involved, and the duration and regulation of the response.

24.14 Acute inflammation

Acute inflammation generally develops rapidly after an injury or an appropriate danger signal. It often involves local blood-vessel changes and the recruitment of neutrophils and other immune cells.

A simplified sequence is:

Tissue-resident cells detect infection, injury, or other danger signals.
Signalling molecules are released or activated.
Nearby blood vessels change their diameter and permeability.
Adhesion molecules on endothelial cells help circulating leukocytes slow down and attach to the vessel wall.
Leukocytes cross the vessel wall into the tissue through a process called extravasation.
Chemical signals guide cells toward the affected area.
Immune cells help remove pathogens or damaged material and coordinate subsequent responses.

The process is more complex than this simplified sequence, and different tissues use different combinations of cells and signals. Nevertheless, it illustrates how local molecular signals can produce a coordinated response across a tissue.

24.15 How leukocytes leave the bloodstream

Leukocyte recruitment involves several stages that allow white blood cells to move from the blood into tissues.

Tethering and rolling: selectins and other interactions allow leukocytes to make transient contacts with the vessel wall.
Activation: chemokines and other signals can activate leukocyte integrins.
Firm adhesion: activated integrins bind endothelial adhesion molecules more strongly.
Transmigration: leukocytes pass between or through endothelial cells and across associated barriers.
Migration within tissue: cells move along chemical and physical cues toward the relevant location.

These steps are regulated. The endothelium, immune cells, local tissue cells, and extracellular matrix all contribute to determining where and how leukocytes are recruited.

Recruitment is essential for defence, but excessive leukocyte accumulation can contribute to tissue damage in some inflammatory diseases.

24.16 Complement: a circulating defence system

The complement system is a collection of proteins found in blood and other body fluids. When activated, complement proteins participate in a cascade of reactions that can enhance microbial defence and inflammation.

Complement can be activated through several pathways, including the classical, lectin, and alternative pathways. These pathways differ in how they begin but converge on shared components of the cascade.

Important complement functions include:

Opsonization: complement fragments can coat microbes and improve their recognition by phagocytes.
Inflammatory signalling: selected fragments can promote inflammatory responses and help recruit or activate immune cells.
Membrane attack complex: terminal complement components can assemble a structure that damages the membranes of susceptible targets.
Immune-complex handling: complement can help process and clear certain complexes formed by antibodies and antigens.

Complement must be regulated to limit damage to the body's own cells. Defects in complement proteins or their regulatory mechanisms can produce susceptibility to infection or contribute to inflammatory and autoimmune conditions.

24.17 Fever and systemic inflammation

Fever is a regulated increase in body temperature that can occur during infection and other inflammatory states. Inflammatory signals can influence pathways in the brain that regulate the body's temperature set point.

Fever is not simply uncontrolled overheating. It is an active physiological response that can affect immune function and the conditions in which pathogens reproduce. However, fever can also cause discomfort and may require assessment depending on its severity, duration, and associated symptoms.

Inflammation can become systemic when signalling extends beyond the original site. In severe cases, widespread immune and vascular responses can interfere with organ function. Sepsis is a life-threatening condition involving a dysregulated response to infection and organ dysfunction; it is not merely another word for any infection or fever.

The severity of a systemic response depends on the infectious agent or trigger, the host's physiology, and the effectiveness of the body's regulatory systems.

24.18 Chronic inflammation

Chronic inflammation persists over an extended period. It can occur when a trigger remains present, when immune regulation is impaired, or when a self-sustaining inflammatory process develops.

Unlike a short-lived acute response, chronic inflammation can involve ongoing interactions among macrophages, lymphocytes, stromal cells, blood vessels, and extracellular-matrix components.

Persistent inflammation may contribute to tissue destruction, abnormal repair, fibrosis, or changes in cellular growth. In some circumstances, long-term inflammatory conditions are associated with increased cancer risk, although the relationship differs among tissues and diseases.

Chronic inflammation is not a single disease. It can arise from persistent infection, autoimmune responses, environmental exposures, metabolic disturbances, or other causes. The appropriate response depends on identifying the underlying process.

24.19 Wound healing and tissue repair

Wound healing involves coordinated responses among platelets, immune cells, epithelial cells, fibroblasts, endothelial cells, and other tissue components.

Platelets contribute to clot formation and release signals that influence subsequent repair. Inflammatory cells remove microbes and damaged material and release mediators that affect surrounding cells.

Fibroblasts can produce extracellular-matrix components, while endothelial cells participate in the formation and remodelling of blood vessels. Epithelial cells can proliferate and migrate to restore barrier surfaces.

Repair involves overlapping phases rather than perfectly separated stages. Inflammation, tissue formation, and remodelling can occur concurrently, and their timing depends on the wound and the condition of the tissue.

Successful healing requires the response to be controlled. Insufficient repair can leave tissue vulnerable, whereas prolonged inflammation or excessive matrix deposition can contribute to chronic wounds or fibrosis.

24.20 Immune tolerance: avoiding attacks on healthy tissue

The immune system must respond to threats while avoiding harmful responses against the body's own structures. This balance is supported by mechanisms collectively called immune tolerance.

Central tolerance occurs during the development of lymphocytes. In the thymus, developing T cells undergo selection processes that remove or alter many cells with inappropriate recognition properties. Developing B cells also undergo tolerance-related processes.

Peripheral tolerance regulates mature lymphocytes outside their primary developmental organs. Mechanisms include regulatory T cells, inhibitory receptors, functional inactivation under certain conditions, and the deletion or suppression of inappropriate immune cells.

Tolerance is not simply the absence of immune activity. It is an actively maintained state involving multiple layers of regulation.

These mechanisms are important because many normal molecules can potentially be recognized by immune receptors. Without adequate regulation, immune responses could damage tissues even when no infection is present.

24.21 Autoimmunity

Autoimmunity occurs when immune responses are directed against the body's own components. Autoimmune diseases arise through different mechanisms and can affect particular organs or multiple systems.

Autoimmune disease does not necessarily mean that every immune cell has lost tolerance or that the entire immune system attacks the whole body. Many conditions involve particular targets, cell populations, and patterns of inflammation.

The development of autoimmunity can involve genetic susceptibility, environmental factors, infections, tissue injury, and changes in immune regulation. The relative contributions vary among diseases.

Autoimmune conditions also differ in their clinical course. Some are predominantly organ-specific, while others involve widespread inflammation or damage across several tissues.

24.22 Allergy and hypersensitivity

An allergy is an immune response to a substance that is usually harmless to most people. Allergic responses can involve antibodies, immune cells, inflammatory mediators, or combinations of mechanisms.

In many common immediate allergic reactions, a person first becomes sensitized to an allergen. Allergen-specific IgE antibodies can bind to receptors on mast cells and basophils. On later exposure, the allergen may cross-link these antibodies and trigger the release of inflammatory mediators.

Histamine is one such mediator. It can contribute to itching, swelling, mucus production, and changes in blood vessels. Other mediators and cell types can contribute to later phases of the response.

Not every allergy follows this exact mechanism. Other forms of hypersensitivity involve different antibodies, immune complexes, or T-cell-mediated responses.

Allergic reactions range from localized symptoms to severe systemic reactions. Their effects depend on the allergen, route of exposure, individual susceptibility, and the type of immune response involved.

24.23 Immunological memory and vaccination

After many adaptive immune responses, some B and T lymphocytes become memory cells. These cells can persist after the initial response and support a faster or more effective response to a later encounter with the same or a related antigen.

Memory B cells can respond to later exposure by producing new populations of antibody-secreting cells. Long-lived plasma cells can also maintain antibody production without requiring a new infection.

Vaccination uses controlled exposure to selected antigens or antigen-producing instructions to help establish protective immune responses without requiring the person to undergo the disease in its usual form.

Different vaccines use different approaches, including weakened pathogens, inactivated pathogens, purified components, viral vectors, or nucleic-acid-based platforms. Their design influences how antigens are produced or presented and which immune responses are stimulated.

Vaccination does not always prevent infection completely. Depending on the vaccine and pathogen, protection may reduce the likelihood of infection, lower the risk of severe disease, reduce transmission, or provide some combination of these effects.

24.24 Immunodeficiency

Immunodeficiency refers to impaired function of one or more components of the immune system. It can be inherited or acquired.

Inherited immunodeficiencies may involve defects in immune-cell development, antibody production, complement proteins, or other defensive mechanisms. Acquired immunodeficiency can arise from infections, particular medications, some cancers, nutritional problems, or other medical conditions.

The consequences depend on which components are affected. A person with impaired antibody production may be particularly vulnerable to certain infections, while defects in cellular immunity can produce a different pattern of susceptibility.

Immunodeficiency does not always mean that every immune function is weak. Some immune defects can coexist with excessive inflammation or abnormal immune regulation.

24.25 Immune surveillance and cancer

Immune cells can recognize and eliminate some abnormal cells, including certain cells that have acquired cancer-associated changes. This activity can help limit tumour development.

However, cancer cells may evolve features that reduce their recognition or suppress the activity of immune cells within the tumour microenvironment.

Some immunotherapies aim to restore effective immune responses by blocking inhibitory pathways, providing immune-targeting antibodies, or using engineered immune cells. These approaches exploit the specificity and regulatory machinery of the immune system.

Immunotherapy is not effective for every tumour. Its success depends on factors such as antigen availability, immune-cell access, the tumour microenvironment, and the mechanisms that the cancer uses to evade immunity.

24.26 Why immune regulation matters

The immune system must coordinate several competing goals: eliminate threats, limit collateral damage, preserve normal tissue, establish useful memory, and return toward a stable state after the threat has passed.

These goals require regulatory mechanisms at multiple levels, including receptor signalling, cytokine production, immune-cell differentiation, cell migration, programmed cell death, and interactions with tissue-resident cells.

Too little activation can permit pathogens or abnormal cells to persist. Too much activation can cause tissue injury. Poorly directed activation can produce autoimmune or allergic disease, while inadequate activation can contribute to immunodeficiency.

Immune responses therefore cannot be understood simply as stronger being better. Their effectiveness depends on specificity, timing, location, coordination, and appropriate termination.

Key idea: Immunity depends on coordinated cellular recognition, communication, and regulation. Innate immunity provides rapid defence, while adaptive immunity provides highly specific responses and memory. Inflammation helps protect and repair tissues, but it must be controlled to prevent unnecessary damage. Immune tolerance, cell recruitment, antigen presentation, and signalling networks are essential for maintaining this balance.

26. Common Misconceptions and Scientific Corrections

Cell biology contains many concepts that sound simple but are easy to oversimplify. Correcting these misunderstandings is important because cellular processes depend on context, interacting systems, and probabilities rather than isolated rules.

26.1 Cells Are Not All the Same

Misconception: Every cell in the body has the same shape, structures, and functions.

Correction: Cells differ in gene expression, size, shape, metabolism, internal organization, and function. A neuron, red blood cell, muscle cell, and intestinal epithelial cell are adapted to different tasks. Most nucleated cells contain broadly similar classes of genetic information, but they use different parts of that information. Mature human red blood cells are an important exception because they lack a nucleus.

26.2 The Nucleus Does Not Direct Every Event Moment by Moment

Misconception: The nucleus directly controls every cellular action.

Correction: The nucleus stores most cellular DNA and regulates many processes through gene expression. However, much cellular activity is carried out by proteins, membranes, organelles, metabolites, and molecular networks that respond to local conditions. Cells also contain mitochondrial DNA, and many organisms have additional forms of genetic organization.

26.3 DNA Does Not Determine Every Outcome by Itself

Misconception: A cell's DNA alone completely determines its structure and behavior.

Correction: DNA provides inherited information, but outcomes also depend on gene regulation, epigenetic states, environmental signals, cellular history, stochastic molecular events, and interactions with other cells. The same genome can support many distinct cell types because different genes are active in different contexts.

26.4 Mutations Are Not Always Harmful

Misconception: Every mutation is damaging.

Correction: Mutations can be harmful, beneficial in particular environments, or have little detectable effect. Some occur in noncoding regions; others change a protein's sequence or the regulation of a gene. Their consequences depend on the mutation, the organism, and the environment. A mutation's effect is not necessarily predictable from its existence alone.

26.5 Enzymes Do Not Make Reactions Possible in Any Direction

Misconception: An enzyme can force any chemical reaction to occur.

Correction: Enzymes lower activation-energy barriers and speed up reactions. They do not change the overall free-energy difference between reactants and products or alter the equilibrium constant of the reaction. Whether a reaction is thermodynamically favorable depends on the conditions, including concentrations. Cells can drive otherwise unfavorable processes by coupling them to favorable reactions, such as ATP hydrolysis.

26.6 ATP Is Not the Cell's Only Energy Carrier

Misconception: ATP is the only molecule involved in cellular energy transfer.

Correction: ATP is a major energy-coupling molecule, but cells also use GTP, reducing equivalents such as NADH and NADPH, electrochemical gradients, and other activated intermediates. Different pathways transfer energy and electrons in different forms.

26.7 Mitochondria Do More Than Produce ATP

Misconception: The only function of mitochondria is energy production.

Correction: Mitochondria also participate in metabolic pathways, calcium handling, signaling, and regulated cell-death pathways. Their functions vary with cell type and physiological state. ATP production is central, but it is not their only role.

26.8 Plant Cells Also Have Mitochondria

Misconception: Plant cells use chloroplasts instead of mitochondria.

Correction: Most plant cells have both mitochondria and chloroplasts. Chloroplasts capture light energy and support photosynthesis in photosynthetic tissues. Mitochondria carry out cellular respiration and other metabolic functions. Plant cells also respire in the light; photosynthesis does not eliminate the need for respiration.

26.9 Not All Cells Have a Cell Wall

Misconception: Every cell has a rigid wall outside its membrane.

Correction: Plant, fungal, and bacterial cells typically have cell walls, although their wall materials differ. Animal cells lack cell walls and instead depend on the plasma membrane, cytoskeleton, cell junctions, and extracellular matrix for organization and mechanical support.

26.10 Prokaryotes Are Not Simply Small Eukaryotes

Misconception: Bacteria are ordinary cells that have lost their nucleus.

Correction: Prokaryotes have distinct cellular organization and evolutionary histories. They generally lack a membrane-enclosed nucleus and the typical membrane-bound organelles of eukaryotes. Their gene expression, genome organization, and cellular machinery differ in important ways from those of eukaryotes. Archaea are also prokaryotes, but they are distinct from bacteria.

26.11 The Cell Membrane Is Not an Impermeable Wall

Misconception: The membrane either blocks everything or lets everything pass.

Correction: The lipid bilayer restricts many charged and polar substances, while particular molecules cross by diffusion, channels, carriers, or energy-dependent transport. Permeability depends on molecular properties and the proteins present. Selective transport allows cells to maintain ion gradients and internal conditions.

26.12 Osmosis Is Not Simply Water Moving Toward Salt

Misconception: Water always moves toward whichever side has more salt.

Correction: Osmosis describes net water movement across a selectively permeable membrane in response to differences in water chemical potential. Solute concentration matters, but so does whether the solute can cross the membrane. Tonicity describes how a solution affects cell volume and depends especially on effectively nonpenetrating solutes.

26.13 Mitosis and Cytokinesis Are Different Processes

Misconception: Mitosis means the entire cell splits into two.

Correction: Mitosis is nuclear division in eukaryotic cells. Cytokinesis divides the cytoplasm and separates daughter cells. They are coordinated, but they are not the same event. Some cells can undergo nuclear division without immediate cytokinesis, producing multinucleated cells.

26.14 Meiosis Does Not Always Produce Four Functional Gametes

Misconception: Every meiotic event produces four equal, functional sex cells.

Correction: Meiosis involves two rounds of division after one round of DNA replication and typically produces haploid products. In human sperm formation, the process can yield four spermatids that mature into sperm. In human egg formation, divisions are unequal and usually produce one large ovum and smaller polar bodies. Details vary among organisms.

26.15 Cell Death Is Not Always Accidental

Misconception: Cell death happens only when cells are physically damaged.

Correction: Cells can undergo regulated death as part of development, tissue maintenance, immune defense, and responses to stress. Apoptosis is one well-studied pathway, but other regulated cell-death mechanisms also exist. Severe injury can cause uncontrolled damage as well.

26.16 Stem Cells Are Not Unlimited Repair Machines

Misconception: Stem cells can replace any damaged cell in any tissue.

Correction: Stem-cell potential depends on the cell type, developmental state, tissue environment, and experimental conditions. Many adult stem cells have restricted differentiation potential. Tissue regeneration can be limited by scarring, inflammation, loss of structural organization, or damage to the stem-cell niche.

26.17 A Microscopic Image Is Not a Perfect Picture of a Living Cell

Misconception: Every structure visible in a micrograph existed exactly that way in the living cell.

Correction: Fixation, dehydration, staining, sectioning, fluorescent labeling, and illumination can alter samples or introduce artifacts. Live-cell imaging can avoid some preparation artifacts but has its own limitations, including phototoxicity and limited resolution. Microscopy findings should be interpreted with suitable controls and complementary methods.

26.18 More Data Does Not Automatically Mean a Better Conclusion

Misconception: A large number of measurements guarantees a reliable result.

Correction: Data quality depends on experimental design, sample selection, measurement validity, controls, replication, statistical analysis, and reproducibility. Many technical measurements from one biological sample do not necessarily replace independent biological replicates.

26.19 Correlation Does Not Prove Causation

Misconception: If a cellular change occurs alongside a disease, that change must cause the disease.

Correction: The change may be a cause, a consequence, a compensatory response, or a marker of another process. Causal evidence often requires controlled perturbations, appropriate comparisons, time-course studies, and experiments that test whether reversing the change alters the outcome.

26.20 Biological Explanations Often Have Exceptions

Misconception: Every rule in an introductory cell-biology textbook applies identically to every cell.

Correction: Introductory rules describe common patterns, not necessarily universal laws. Mature red blood cells, multinucleated muscle fibers, unusual organelles, specialized immune cells, and diverse microbial life illustrate the range of cellular organization. A good explanation states the conditions under which a generalization applies.

Key idea: Accurate cell biology requires distinguishing a useful simplified model from the full biological process. Mechanisms, experimental evidence, and context matter more than memorizing oversimplified rules.

28. Further Reading and Reliable Learning Resources

Cell biology is a broad and evolving field. The resources below provide ways to explore the subject beyond this introductory guide. Textbooks are useful for building a connected understanding, while scientific databases and educational websites help readers investigate individual topics and newer findings.

28.1 Open Educational Resources

OpenStax Biology 2e

A free, peer-reviewed introductory biology textbook covering cells, membranes, metabolism, genetics, cell division, and related topics. It is useful for readers who want a structured introduction before moving to specialized cell biology.

Read OpenStax Biology 2e

NCBI Bookshelf

The National Center for Biotechnology Information Bookshelf provides access to selected biomedical books and reference works. It can be useful when a topic requires more depth than a general introductory textbook provides. The collection and access conditions vary by title.

Explore NCBI Bookshelf

HHMI BioInteractive

HHMI BioInteractive provides educational resources, videos, activities, and scientific visualizations. These materials can help connect abstract cellular mechanisms to experiments and biological evidence.

Explore HHMI BioInteractive

28.2 Scientific Literature and Research Databases

PubMed

PubMed is a searchable database of biomedical and life-science literature. It includes references and abstracts for many scientific papers, along with links to full text when available. Not every indexed article is freely accessible in full.

Search PubMed

Europe PMC

Europe PMC provides access to life-science literature, abstracts, and links to full-text articles, including a substantial collection of open-access research. It also offers tools for searching biomedical publications and related research information.

Search Europe PMC

Directory of Open Access Journals (DOAJ)

DOAJ indexes open-access journals that meet its selection criteria. It can help readers locate freely accessible scholarly articles, although inclusion in a directory does not eliminate the need to evaluate the quality and relevance of an individual study.

Search DOAJ

28.3 Molecular and Cellular Data Resources

UniProt

UniProt provides protein sequence and functional information, including annotations about protein domains, cellular locations, biological roles, and related references. Annotations differ in evidence level, so check whether information is experimentally supported, inferred, or predicted.

Explore UniProt

Gene Expression Omnibus (GEO)

GEO, maintained by NCBI, archives many functional genomics datasets, including gene-expression studies. It is useful for exploring how gene activity changes across cell types, treatments, and disease conditions. Reanalysis requires attention to sample design, metadata, normalization, and technical limitations.

Explore GEO datasets

Human Protein Atlas

The Human Protein Atlas presents information about protein expression in human tissues and cells, including immunohistochemistry and other experimental data. Different data types have different limitations, and staining should not be treated as a perfect quantitative measurement of protein abundance.

Explore the Human Protein Atlas

RCSB Protein Data Bank

The Protein Data Bank provides three-dimensional structural data for proteins, nucleic acids, and molecular complexes. Structural models help explain molecular interactions, but a structure represents a particular experimental or computational model and may not capture every dynamic state of a molecule.

Explore the Protein Data Bank

28.4 Textbooks for Deeper Study

The following established textbooks are useful references for different levels of study. Availability, editions, and access options vary.

Molecular Biology of the Cell — Bruce Alberts and colleagues. A detailed treatment of cell structure, molecular mechanisms, signaling, genetics, and cellular organization.
The Cell: A Molecular Approach — Geoffrey M. Cooper and colleagues in relevant editions. A molecularly focused introduction to cellular processes.
Essential Cell Biology — Bruce Alberts and colleagues. A more concise introduction to major cellular concepts and mechanisms.
Lehninger Principles of Biochemistry — David L. Nelson and Michael M. Cox in relevant editions. A useful companion for metabolism, enzymes, proteins, and bioenergetics.

When using a textbook, check the edition and publication date. Foundational mechanisms are often stable, but details, examples, and scientific interpretations can change as evidence accumulates.

28.5 How to Read a Scientific Paper

Reading a research article is different from reading a textbook. A paper usually addresses a narrower question and reports a particular set of experiments or analyses.

Read the title and abstract. Identify the question, the system studied, and the main conclusion.
Check the background. Determine what was already known and what gap the researchers intended to address.
Inspect the methods. Note the cell type, organism, sample size, experimental conditions, controls, and measurement techniques.
Examine the figures. Read axis labels, units, legends, sample sizes, and statistical comparisons. Ask what each experiment directly measures.
Separate results from interpretation. A measured change is not always proof of the proposed mechanism.
Look for limitations. Consider alternative explanations, missing controls, sample-selection issues, and whether the results generalize beyond the system studied.
Check related work. Look for independent replication, follow-up studies, and evidence that supports or challenges the conclusion.

28.6 A Suggested Learning Path

Start with the foundations: cell theory, basic chemistry, water, macromolecules, and the distinction between prokaryotic and eukaryotic cells.
Learn cell architecture: membranes, organelles, cytoskeleton, extracellular matrix, and compartmentalization.
Understand molecular information: DNA replication, transcription, translation, gene regulation, and protein structure.
Study energy and transport: enzymes, ATP, cellular respiration, photosynthesis, diffusion, osmosis, and active transport.
Connect cells to one another: receptors, signaling pathways, cell junctions, cell adhesion, and extracellular communication.
Study cell fate: the cell cycle, mitosis, meiosis, differentiation, stem cells, senescence, and regulated cell death.
Apply the concepts: investigate infection, cancer, inherited disorders, tissue repair, and laboratory diagnosis.
Read primary research: choose a focused question and compare evidence from multiple studies rather than relying on a single abstract.

28.7 Evaluating Scientific Sources

Not all sources have the same purpose. A textbook is designed to explain established knowledge; a research article reports a specific study; a review synthesizes multiple studies; and a popular article may simplify findings for a general audience.

Prefer sources that identify their authors, publication date, evidence, and references.
Check whether a claim comes from an experiment, a review, an expert interpretation, or a hypothesis.
Distinguish findings in cultured cells or model organisms from findings demonstrated in humans.
Be cautious with claims that one molecule or pathway explains an entire complex disease.
Remember that a published study can contain limitations, and scientific consensus may develop through the comparison of many independent results.

28.8 Final Perspective

Cell biology links chemistry and physics to genetics, physiology, evolution, and medicine. Cells are not static containers; they are organized, dynamic systems that exchange matter and energy, maintain internal conditions, interpret signals, and change over time.

A strong understanding comes from connecting structures to functions, mechanisms to evidence, and molecular events to the behavior of tissues and organisms. The goal is not merely to memorize organelles or pathways, but to understand how the parts work together—and how experiments allow scientists to test those explanations.

PS: Written with the assistance of ChatGPT.